Lance Liotta

Q: What Schools Are Affiliated With Lance Liotta

Lance Liotta is affiliated with the following schools: Magna Græcia University, Technical University of Munich, University of Chicago, Ohio State University, University of Turin, University of Virginia, University of Tübingen, George Mason University, Johns Hopkins University, Yale University, University of Modena and Reggio Emilia, University of Oklahoma, University of Padua, Texas A&M University, Hiram College

Lance Liotta's AcademicInfluence.com Rankings

Philosophy

#1385

World Rank

#2324

Historical Rank

Logic

#239

World Rank

#503

Historical Rank

philosophy Degrees

Biology

#1481

World Rank

#2526

Historical Rank

Pathology

#11

World Rank

#21

Historical Rank

biology Degrees

Why Is Lance Liotta Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Lance A. Liotta is the Co-Director and Co-Founder of the Center for Applied Proteomics and Molecular Medicine at George Mason University. His research team was the first to propose the existence of the autocrine motility factor. In 1985, he received the Rhoads Award from the American Association for Cancer Research. In 1987, he received the National Lectureship Award from the American Association for Clinical Chemistry. His other awards include the Warner-Lambert Parke Davis Award and the Surgeon General's Medallion.

(See a Problem?)

Lance Liotta's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Papers

Use of proteomic patterns in serum to identify ovarian cancer (2002) (3136)
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (2012) (2913)
Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. (1986) (2840)
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation (1991) (2828)
The microenvironment of the tumour–host interface (2001) (2346)
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. (2003) (2209)
Positional cloning of the gene for multiple endocrine neoplasia-type 1. (1997) (1906)
Metastatic potential correlates with enzymatic degradation of basement membrane collagen (1980) (1829)
Tumor cell interactions with the extracellular matrix during invasion and metastasis. (1993) (1563)
Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture. (1986) (1467)
Evidence for a novel gene associated with low tumor metastatic potential. (1988) (1327)
Laser-capture microdissection (2006) (1290)
Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. (1982) (1244)
Laser Capture Microdissection (1996) (1057)
Tumor invasion and the extracellular matrix. (1983) (1011)
Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front (2001) (933)
Laser Capture Microdissection: Molecular Analysis of Tissue (1997) (883)
Tumor invasion and metastasis: an imbalance of positive and negative regulation. (1991) (833)
Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. (1974) (821)
General mechanisms of metastasis (1997) (807)
Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. (1989) (806)
Serum proteomic patterns for detection of prostate cancer. (2002) (754)
Biochemical interactions of tumor cells with the basement membrane. (1986) (710)
Laser capture microdissection. (1996) (639)
Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. (1981) (630)
Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance (2007) (621)
Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis (1993) (608)
The significance of hematogenous tumor cell clumps in the metastatic process. (1976) (603)
Early detection: Proteomic applications for the early detection of cancer (2003) (583)
Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm3-transfected melanoma cells (1991) (576)
Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. (1992) (570)
Clinical proteomics: translating benchside promise into bedside reality (2002) (550)
Loss of basement membrane components by invasive tumors but not by their benign counterparts. (1983) (538)
Tumor cell autocrine motility factor. (1986) (523)
Molecular insights into cancer invasion: strategies for prevention and intervention. (1995) (510)
Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development (1989) (504)
Clinical proteomics: Written in blood (2003) (495)
Molecular aspects of tumor cell invasion and metastasis (1993) (482)
Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays (2003) (463)
Laser-capture microdissection: opening the microscopic frontier to molecular analysis. (1998) (463)
Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. (1997) (461)
Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor. (1979) (444)
Molecular profiling of human cancer (2000) (433)
Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. (1989) (432)
Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. (1990) (432)
Protein microarrays: meeting analytical challenges for clinical applications. (2003) (424)
Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor (1990) (407)
Isolation of a tumor cell laminin receptor. (1983) (405)
Metalloproteinases and cancer invasion. (1990) (405)
Somatic mutation of the MEN1 gene in parathyroid tumours (1997) (401)
Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. (1990) (396)
Laminin receptor on human breast carcinoma cells. (1983) (391)
Immuno-LCM: laser capture microdissection of immunostained frozen sections for mRNA analysis. (1999) (387)
Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. (2005) (386)
2D Differential In-gel Electrophoresis for the Identification of Esophageal Scans Cell Cancer-specific Protein Markers* (2002) (383)
Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. (1992) (371)
Multiple Endocrine Neoplasia Type 1: Clinical and Genetic Topics (1998) (357)
Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. (1990) (354)
Role of laminin in the attachment and metastasis of murine tumor cells. (1982) (353)
Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. (2001) (350)
A Drosophila gene that is homologous to a mammalian gene associated with tumor metastasis codes for a nucleoside diphosphate kinase (1990) (343)
Tumor cell invasion inhibited by TIMP-2. (1991) (341)
Breast cancer growth prevention by statins. (2006) (339)
Basement membrane collagen: degradation by migrating endothelial cells. (1983) (336)
The blood peptidome: a higher dimension of information content for cancer biomarker discovery (2006) (334)
The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation. (1989) (328)
SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. (2004) (327)
Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. (1995) (324)
Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells (1990) (322)
Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study (2007) (316)
Use of Reverse Phase Protein Microarrays and Reference Standard Development for Molecular Network Analysis of Metastatic Ovarian Carcinoma* (2005) (311)
Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays (2000) (305)
Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer (2002) (300)
An investigation into the human serum “interactome” (2004) (299)
Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. (1996) (299)
Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. (1991) (295)
A microdissection technique for archival DNA analysis of specific cell populations in lesions < 1 mm in size. (1995) (294)
TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase (1992) (291)
Angiogenesis: role of calcium-mediated signal transduction. (1995) (288)
Proteomic profiling of the cancer microenvironment by antibody arrays (2001) (288)
Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis. (1988) (284)
Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. (1996) (283)
Proteomic Patterns of Nipple Aspirate Fluids Obtained by SELDI-TOF: Potential for New Biomarkers to Aid in the Diagnosis of Breast Cancer (2002) (273)
High-resolution serum proteomic features for ovarian cancer detection. (2004) (267)
Cancer cell invasion and metastasis. (1992) (262)
Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. (1994) (261)
Modulation of the metastatic activity of melanoma cells by laminin and fibronectin. (1984) (258)
Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. (1994) (254)
Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold. (2005) (253)
Monoclonal origin of multicentric Kaposi's sarcoma lesions. (1997) (250)
Elevated Levels of Mr 92,000 Type IV Collagenase in Human Brain Tumors (1993) (248)
NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude mice (1985) (246)
Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a. (1987) (245)
Altered levels of laminin receptor mRNA in various human carcinoma cells that have different abilities to bind laminin. (1986) (244)
Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. (1996) (243)
Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. (1997) (238)
Mutations of the MEN1 tumor suppressor gene in pituitary tumors. (1997) (235)
Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival. (2007) (234)
Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. (2003) (232)
Role of laminin receptor in tumor cell migration. (1987) (230)
Purification and characterization of a murine basement membrane collagen-degrading enzyme secreted by metastatic tumor cells. (1983) (228)
Protein microarrays: Molecular profiling technologies for clinical specimens (2003) (225)
Signal pathway profiling of ovarian cancer from human tissue specimens using reverse‐phase protein microarrays (2003) (220)
Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. (2000) (220)
Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression. (1991) (220)
Increased content of Type V Collagen in desmoplasia of human breast carcinoma. (1982) (217)
Evidence for a precursor of the high-affinity metastasis-associated murine laminin receptor. (1989) (217)
Clinical proteomics: personalized molecular medicine. (2001) (216)
New method for preparing large surfaces of intact human basement membrane for tumor invasion studies. (1980) (216)
Partial purification and characterization of a neutral protease which cleaves type IV collagen. (1981) (214)
cDNA cloning of the human tumor motility-stimulating protein, autotaxin, reveals a homology with phosphodiesterases. (1994) (213)
Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. (2000) (205)
Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains (1987) (204)
A Portrait of Tissue Phosphoprotein Stability in the Clinical Tissue Procurement Process* (2008) (201)
Biomarker Amplification by Serum Carrier Protein Binding (2004) (201)
Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor. (2001) (200)
Primary rat embryo cells transformed by one or two oncogenes show different metastatic potentials. (1986) (200)
Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions. (1992) (197)
Anoikis: Cancer and the homeless cell (2004) (197)
Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells – role in metastasis (1982) (196)
Signal pathway profiling of prostate cancer using reverse phase protein arrays (2003) (194)
Interactions of basement membrane components. (1983) (193)
Laminin increases the release of type IV collagenase from malignant cells. (1986) (191)
Immunochemical and ultrastructural assessment of the nature of the pericellular basement membrane of human decidual cells. (1985) (190)
Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells (2000) (189)
Protein microarray detection strategies: focus on direct detection technologies. (2004) (188)
Tumor vascular proteins as biomarkers in ovarian cancer. (2007) (188)
Laminin molecular domains which alter metastasis in a murine model. (1984) (187)
Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell. (1985) (185)
Analysis of albumin-associated peptides and proteins from ovarian cancer patients. (2005) (182)
Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group. (2002) (181)
The elastin receptor shows structural and functional similarities to the 67-kDa tumor cell laminin receptor. (1989) (180)
Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy. (2005) (180)
Proteomic analysis of eccrine sweat: implications for the discovery of schizophrenia biomarker proteins. (2012) (178)
Effects of inhibition of basement membrane collagen deposition on rat mammary gland development. (1980) (177)
Cancer diagnosis using proteomic patterns (2003) (174)
Mechanism of Cell Adaptation: When and How Do Cancer Cells Develop Chemoresistance? (2011) (173)
Cancer invasion and metastasis. (1993) (172)
Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival. (1991) (171)
Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential. (1985) (171)
Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias. (1999) (171)
Effects of free fatty acids on the growth of normal and neoplastic rat mammary epithelial cells. (1979) (170)
Formation of metastasis by human breast carcinoma cells (MCF-7) in nude mice. (1980) (168)
Isolation of a subunit of laminin and its role in molecular structure and tumor cell attachment. (1982) (167)
Activation of human breast carcinoma collagenase through plasminogen activator. (1980) (167)
Cancer: Out of air is not out of action (2003) (166)
Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling. (2003) (166)
Autotaxin Is an Exoenzyme Possessing 5′-Nucleotide Phosphodiesterase/ATP Pyrophosphatase and ATPase Activities* (1997) (166)
Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors. (1997) (165)
Safety and Biologic Response of Pre-operative Autophagy Inhibition in Combination with Gemcitabine in Patients with Pancreatic Adenocarcinoma (2015) (164)
Basement membrane collagen requirements for attachment and growth of mammary epithelium. (1979) (164)
Proteins, drug targets and the mechanisms they control: the simple truth about complex networks (2007) (163)
Proteolytic enzymes in cancer invasion and metastasis. (1986) (162)
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements. (2008) (161)
Signal Pathways Which Promote Invasion and Metastasis: Critical and Distinct Contributions of Extracellular Signal-Regulated Kinase and Ral-Specific Guanine Exchange Factor Pathways (2001) (160)
Molecular cytogenetic fingerprinting of esophageal squamous cell carcinoma by comparative genomic hybridization reveals a consistent pattern of chromosomal alterations (1999) (160)
Degradation of basement membrane by murine tumor cells. (1977) (159)
Role of collagenases in tumor cell invasion (2004) (158)
Laser capture microdissection technology (2007) (158)
Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip (2000) (158)
The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids. (1997) (158)
Differential response to growth factor by rat mammary epithelium plated on different collagen substrata in serum-free medium. (1981) (156)
Laser capture microdissection and microarray expression analysis of lung adenocarcinoma reveals tobacco smoking- and prognosis-related molecular profiles. (2002) (156)
Molecular mediators of interactions with extracellular matrix components in metastasis and angiogenesis. (1994) (155)
Mitochondrial proteome: Altered cytochrome c oxidase subunit levels in prostate cancer (2003) (153)
Physiological mechanisms of tumor-cell invasion and migration. (2005) (153)
Expression of laminin receptor in normal and carcinomatous human tissues as defined by a monoclonal antibody. (1985) (153)
Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM). (1997) (152)
Mouse endometrial stromal cells produce basement-membrane components. (1986) (151)
Laminin binds specifically to sulfated glycolipids. (1985) (149)
Effect of natural protease inhibitors and a chemoattractant on tumor cell invasion in vitro. (1982) (146)
Cytokine-induced pseudopodial protrusion is coupled to tumour cell migration (1987) (146)
Malignant Precursor Cells Pre-Exist in Human Breast DCIS and Require Autophagy for Survival (2010) (146)
Immunohistochemical localization of matrix metallloproteinase 2 and its specific inhibitor timp‐2 in neoplastic tissues with monclonal antibodies (1994) (146)
The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells. (1989) (145)
Cancer invasion and metastasis: positive and negative regulatory elements. (1991) (145)
Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptor. (1990) (143)
Cancer invasion and metastases. (1990) (143)
Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer. (1995) (143)
Tumor Invasion and Metastasis (1982) (142)
Evidence of independent origin of multiple tumors from patients with prostate cancer. (1998) (140)
Use of anti‐basement membrane antibodies to distinguish blood vessel capillaries from lymphatic capillaries (1983) (138)
Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients. (1996) (137)
Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy. (1992) (136)
Reverse phase protein microarrays advance to use in clinical trials (2010) (136)
Serum proteomics in cancer diagnosis and management. (2004) (136)
Sensitive immunoassay of tissue cell proteins procured by laser capture microdissection. (2000) (135)
Calcium influx modulates expression of matrix metalloproteinase-2 (72-kDa type IV collagenase, gelatinase A). (1994) (135)
Realizing the Promise of Reverse Phase Protein Arrays for Clinical, Translational, and Basic Research: A Workshop Report (2014) (134)
Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy. (2008) (134)
Increased expression of the laminin receptor in human colon cancer. (1991) (133)
CAIR-1/BAG-3 forms an EGF-regulated ternary complex with phospholipase C-γ and Hsp70/Hsc70 (2000) (132)
Adhesion characteristics of murine metastatic and nonmetastatic tumor cells in vitro. (1980) (131)
Glycolysis as primary energy source in tumor cell chemotaxis. (1990) (129)
New technologies for biomarker analysis of prostate cancer progression: Laser capture microdissection and tissue proteomics. (2001) (129)
Batimastat, a potent matrix mealloproteinase inhibitor, exhibits an unexpected mode of binding. (1996) (129)
L651582: a novel antiproliferative and antimetastasis agent. (1990) (128)
Distribution of the 72-kd type IV collagenase in nonneoplastic and neoplastic thyroid tissue. (1992) (127)
A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus. (1997) (126)
Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1. (1997) (126)
Clinical bioinformatics: a new emerging science (2011) (122)
Technology Insight: pharmacoproteomics for cancer—promises of patient-tailored medicine using protein microarrays (2006) (122)
Injury-induced 92-kilodalton gelatinase and urokinase expression in rat brain. (1994) (122)
Clinical Proteomics: From Biomarker Discovery and Cell Signaling Profiles to Individualized Personal Therapy (2005) (122)
CSF proteome: a protein repository for potential biomarker identification (2005) (121)
Proteomic approaches to the diagnosis, treatment, and monitoring of cancer. (2003) (121)
Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml. (2004) (119)
Pegylated, steptavidin-conjugated quantum dots are effective detection elements for reverse-phase protein microarrays. (2005) (119)
In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate, and inositol phosphates. (1992) (118)
Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas (2004) (117)
Smart hydrogel particles: biomarker harvesting: one-step affinity purification, size exclusion, and protection against degradation. (2008) (116)
Clinical potential of proteomics in the diagnosis of ovarian cancer (2002) (116)
Circulating autoantibodies to phosphorylated α-enolase are a hallmark of pancreatic cancer. (2011) (116)
Fibrosarcoma cells transduced with the IL-6 gene exhibited reduced tumorigenicity, increased immunogenicity, and decreased metastatic potential. (1992) (115)
Hormonal requirements for basement membrane collagen deposition by cultured rat mammary epithelium. (1979) (115)
Stages of neoplastic transformation of human breast tissue as monitored by dissolution of basement membrane components. An immunoperoxidase study. (1981) (114)
Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma. (1996) (114)
Secreted Neutral Metalloproteases of Bacillus anthracis as Candidate Pathogenic Factors* (2006) (113)
Transient expression of type IV collagenolytic metalloproteinase by human mononuclear phagocytes. (1986) (113)
TYPE IV COLLAGENASE IMMUNOREACTIVITY IN INVASIVE BREAST CARCINOMA (1983) (111)
A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples. (2007) (110)
Cleavage of laminin by thrombin and plasmin: alpha thrombin selectively cleaves the beta chain of laminin. (1981) (110)
Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers. (1996) (110)
Clinical proteomics: revolutionizing disease detection and patient tailoring therapy. (2004) (109)
Proteomic analysis for the early detection and rational treatment of cancer--realistic hope? (2005) (109)
Utility of reverse phase protein arrays: applications to signalling pathways and human body arrays. (2002) (108)
Cloning, chromosomal localization, and tissue expression of autotaxin from human teratocarcinoma cells. (1996) (108)
Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis. (2006) (108)
Retinal pigment epithelium (RPE) exosomes contain signaling phosphoproteins affected by oxidative stress. (2013) (108)
Evaluation of Basement Membrane Components and the 72 kDa Type IV Collagenase in Serous Tumors of the Ovary (1992) (108)
Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors. (1993) (107)
Development of a prostate cDNA microarray and statistical gene expression analysis package (2000) (107)
Proteomic Analysis of Apoptotic Pathways Reveals Prognostic Factors in Follicular Lymphoma (2005) (107)
Type V collagen in human amnion is a 12 nm fibrillar component of the pericellular interstitium. (1984) (105)
What is the malignant nature of human ductal carcinoma in situ? (2011) (105)
Molecular Analysis of HER2 Signaling in Human Breast Cancer by Functional Protein Pathway Activation Mapping (2012) (104)
Insulin-like growth factors stimulate chemotaxis in human melanoma cells. (1988) (103)
Spatiotemporal segregation of endothelial cell integrin and nonintegrin extracellular matrix-binding proteins during adhesion events (1990) (103)
Molecular profiling of clinical tissues specimens: feasibility and applications. (2000) (102)
Structure-function analysis of signal and growth inhibition by carboxyamido-triazole, CAI. (1994) (101)
A model for CD8+ CTL tumor immunosurveillance and regulation of tumor escape by CD4 T cells through an effect on quality of CTL. (1999) (101)
IF-LCM: laser capture microdissection of immunofluorescently defined cells for mRNA analysis rapid communication. (2000) (100)
The antiproliferative and antimetastatic compound L651582 inhibits muscarinic acetylcholine receptor-stimulated calcium influx and arachidonic acid release. (1991) (100)
Molecular profiling of clinical tissue specimens: feasibility and applications. (2000) (100)
Integrated Genomic and Epigenomic Analysis of Breast Cancer Brain Metastasis (2014) (99)
Adult human keratinocytes migrating over nonviable dermal collagen produce collagenolytic enzymes that degrade type I and type IV collagen. (1986) (99)
Mass spectrometry-based diagnostics: the upcoming revolution in disease detection. (2003) (98)
Prognosis of gastric carcinoma revealed by interactions between tumor cells and basement membrane. (1994) (96)
Integrin Mediates Chemotactic and Haptotactic Motility in Human Melanoma Cells through Different Signaling Pathways (*) (1996) (95)
Tissue is alive: New technologies are needed to address the problems of protein biomarker pre‐analytical variability (2009) (95)
Pertussis toxin inhibits stimulated motility independently of the adenylate cyclase pathway in human melanoma cells. (1987) (95)
Detection of autocrine motility factor in urine as a marker of bladder cancer. (1988) (95)
Urine lipoarabinomannan glycan in HIV-negative patients with pulmonary tuberculosis correlates with disease severity (2017) (94)
Dynamic Profiling of the Post-translational Modifications and Interaction Partners of Epidermal Growth Factor Receptor Signaling after Stimulation by Epidermal Growth Factor Using Extended Range Proteomic Analysis (ERPA)*S (2006) (94)
Clinical Proteomics and Biomarker Discovery (2004) (93)
Laminin receptors, collagenase IV and prognosis in node‐negative breast cancers (1991) (93)
Distribution of a 69-kD laminin-binding protein in aortic and microvascular endothelial cells: modulation during cell attachment, spreading, and migration (1988) (92)
A mathematical model of combination therapy using the EGFR signaling network. (2005) (92)
Multifunctional Core–Shell Nanoparticles: Discovery of Previously Invisible Biomarkers (2011) (92)
Evaluation of hepatocellular carcinoma aggressiveness by a panel of extracellular matrix antigens. (1991) (92)
Use of proteomic analysis to monitor responses to biological therapies (2004) (92)
Modulation of laminin receptor expression by estrogen and progestins in human breast cancer cell lines. (1988) (91)
Importance of communication between producers and consumers of publicly available experimental data. (2005) (91)
Immunoassay of type IV collagenase/gelatinase (MMP-2) in human plasma. (1992) (91)
Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer. (1998) (90)
Core-Shell Hydrogel Particles Harvest, Concentrate and Preserve Labile Low Abundance Biomarkers (2009) (90)
Collagen required for proliferation of cultured connective tissue cells but not their transformed counterparts (1978) (90)
Comparison of the specificities of laminin, thrombospondin, and von Willebrand factor for binding to sulfated glycolipids. (1986) (89)
A Randomized Phase II Preoperative Study of Autophagy Inhibition with High-Dose Hydroxychloroquine and Gemcitabine/Nab-Paclitaxel in Pancreatic Cancer Patients (2020) (89)
Ewing's sarcoma. Characterization in established cultures and evidence of its histogenesis. (1982) (89)
Clues to the function of Nm23 and Awd proteins in development, signal transduction, and tumor metastasis provided by studies of Dictyostelium discoideum. (1990) (88)
Molecular Profiling (2012) (87)
CAIR-1/BAG-3 forms an EGF-regulated ternary complex with phospholipase C-gamma and Hsp70/Hsc70. (2000) (87)
An initial characterization of the serum phosphoproteome. (2009) (87)
Serum Proteomic Analysis Identifies a Highly Sensitive and Specific Discriminatory Pattern in Stage 1 Breast Cancer (2007) (87)
The needle in the haystack: Application of breast fine‐needle aspirate samples to quantitative protein microarray technology (2007) (86)
Basement Membrane Production by Hepatocytes in Chronic Liver Disease (1984) (86)
Toxicoproteomics: Serum Proteomic Pattern Diagnostics for Early Detection of Drug Induced Cardiac Toxicities and Cardioprotection (2004) (86)
Direct visualization of the clonal progression of primary cutaneous melanoma: application of tissue microdissection and comparative genomic hybridization. (1995) (86)
Modulation of type‐iv collagenase activity and invasive behavior of metastatic human melanoma (A2058) cells in vitro by monoclonal antibodies to type‐iv collagenase (1990) (85)
Selective binding and enrichment for low‐molecular weight biomarker molecules in human plasma after exposure to nanoporous silica particles (2006) (85)
Clinical applications of proteomics. (2003) (85)
Autotaxin, tumor motility-stimulating exophosphodiesterase. (1997) (85)
Clinical Applications of Proteomics: Proteomic Pattern Diagnostics (2002) (84)
Laser Capture Microdissection and Protein Microarray Analysis of Human Non-small Cell Lung Cancer (2008) (83)
Genomic and proteomic technologies for individualisation and improvement of cancer treatment. (2004) (83)
Cancer: An attractive force in metastasis (2001) (83)
Monoclonal antibodies to the human laminin receptor recognize structurally distinct sites. (1985) (81)
Isolation of laminin by affinity chromatography on immobilized Griffonia simplicifolia I lectin (1982) (80)
Cancer's deadly signature (2003) (80)
Phase I trial of micronized formulation carboxyamidotriazole in patients with refractory solid tumors: pharmacokinetics, clinical outcome, and comparison of formulations. (1997) (80)
Allelic deletion at chromosome 9p21(p16) and 17p13(p53) in microdissected sporadic dysplastic nevus. (1998) (80)
Laminin promotes rabbit neutrophil motility and attachment. (1986) (80)
Evidence of Independent Origin of Multiple Tumors From Patients With Prostate Cancer (1998) (79)
The amplified peptidome: the new treasure chest of candidate biomarkers. (2006) (79)
One-Step Preservation of Phosphoproteins and Tissue Morphology at Room Temperature for Diagnostic and Research Specimens (2011) (79)
Polymorphonuclear leukocyte migration through human amnion membrane (1981) (78)
Cloning and characterization of human tumor cell interstitial collagenase. (1990) (77)
The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancer. (2003) (77)
Proteomic analysis of lymph (2004) (77)
Tumor invasion and metastases: biochemical mechanisms. (1988) (77)
Advances in Serodiagnostic Testing for Lyme Disease Are at Hand (2018) (77)
Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast. (1997) (77)
Biomarkers of ovarian tumours. (2004) (77)
Desmoplastic breast carcinoma as a source of human myofibroblasts. (1984) (77)
Cancer proteomics: from biomarker discovery to signal pathway profiling. (2001) (77)
Expression of human recombinant 72 kDa gelatinase and tissue inhibitor of metalloproteinase-2 (TIMP-2): characterization of complex and free enzyme. (1993) (76)
Construction of a representative cDNA library from prostatic intraepithelial neoplasia. (1996) (75)
Reverse-phase protein microarrays: application to biomarker discovery and translational medicine (2007) (75)
Functional Protein Pathway Activation Mapping of the Progression of Normal Skin to Squamous Cell Carcinoma (2012) (75)
Identification of a type V collagenolytic enzyme. (1981) (75)
Students Who Demonstrate Strong Talent and Interest in STEM Are Initially Attracted to STEM through Extracurricular Experiences (2014) (75)
The Vision for a New Diagnostic Paradigm (2003) (74)
Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma. (2005) (74)
Elastic behavior of postmortem human lungs: effects of aging and mild emphysema. (1975) (72)
Reactive oxygen species activate NFκB (p65) and p53 and induce apoptosis in RVFV infected liver cells. (2014) (72)
Nanoporous surfaces as harvesting agents for mass spectrometric analysis of peptides in human plasma. (2006) (72)
Urinary type IV collagenase: elevated levels are associated with bladder transitional cell carcinoma. (1992) (72)
Biochemical mechanisms of tumor invasion and metastases. (1988) (71)
Immunocytochemical enhancement of basement membrane antigens by pepsin: applications in diagnostic pathology. (1984) (70)
Heterogeneity of the motility responses in malignant tumor cells: A biological basis for the diversity and homing of metastatic cells (1990) (70)
Application of molecular technologies for phosphoproteomic analysis of clinical samples (2014) (70)
Metastasis suppressor genes. (1991) (70)
Proteomic Analysis of Malignant Ovarian Cancer Effusions as a Tool for Biologic and Prognostic Profiling (2006) (70)
Combination of SELDI-TOF-MS and Data Mining Provides Early-stage Response Prediction for Rectal Tumors Undergoing Multimodal Neoadjuvant Therapy (2007) (69)
Diffusion model of tumor vascularization and growth (1977) (68)
Proteomic analysis reveals Warburg effect and anomalous metabolism of glutamine in pancreatic cancer cells. (2012) (68)
Genomic and proteomic approaches for studying human cancer: Prospects for true patient-tailored therapy (2004) (67)
A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancer (2014) (66)
Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing (2010) (66)
Pathology of the Future: Molecular Profiling for Targeted Therapy (2005) (66)
Antiretroviral Drugs Alter the Content of Extracellular Vesicles from HIV-1-Infected Cells (2018) (66)
Molecular Diagnostics (2023) (65)
Platform for establishing interlaboratory reproducibility of selected reaction monitoring-based mass spectrometry peptide assays. (2010) (65)
Mass spectrometry analysis of the post-translational modifications of alpha-enolase from pancreatic ductal adenocarcinoma cells. (2010) (65)
Localization of the multiple endocrine neoplasia type I (MEN1) gene based on tumor loss of heterozygosity analysis. (1997) (65)
Clinical proteomics: Applications for prostate cancer biomarker discovery and detection. (2004) (64)
A nondestructive molecule extraction method allowing morphological and molecular analyses using a single tissue section (2005) (64)
Nanoparticle technology: addressing the fundamental roadblocks to protein biomarker discovery. (2010) (64)
Proteomic evaluation of archival cytologic material using SELDI affinity mass spectrometry: potential for diagnostic applications. (2002) (64)
PMCA2 regulates HER2 protein kinase localization and signaling and promotes HER2-mediated breast cancer (2016) (64)
Immunohistochemical profile of basement membrane proteins and 72 kilodalton type IV collagenase in the implantation placental site. An integrated view. (1992) (64)
Use of immuno-LCM to identify the in situ expression profile of cellular constituents of the tumor microenvironment (2006) (63)
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in bronchial squamous preinvasive lesions. (2000) (63)
Expression and immunohistochemical localization of cathepsin L during the progression of human gliomas (2004) (63)
Adenosine receptor mediates motility in human melanoma cells. (1998) (63)
Genomics and proteomics: application of novel technology to early detection and prevention of cancer. (2002) (63)
The Goodpasture-like syndrome in mice induced by intravenous injections of anti-type IV collagen and anti-laminin antibody. (1982) (63)
Physicochemically modified silicon as a substrate for protein microarrays. (2007) (62)
Accurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis. (2006) (62)
Laminin production by human endometrial stromal cells relates to the cyclic and pathologic state of the endometrium. (1986) (62)
Interlaboratory reproducibility of selective reaction monitoring assays using multiple upfront analyte enrichment strategies. (2012) (62)
A Functional Polymorphism in RGS6 Modulates the Risk of Bladder Cancer (2004) (62)
Autocrine motility factor stimulates a three-fold increase in inositol trisphosphate in human melanoma cells. (1990) (61)
Quantitative cell signalling analysis reveals down‐regulation of MAPK pathway activation in colorectal cancer (2009) (61)
Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures. (2009) (61)
Interaction of fibronectin with C1q and its collagen‐like fragment (CLF) (1981) (61)
Enrichment of PI3K-AKT–mTOR Pathway Activation in Hepatic Metastases from Breast Cancer (2017) (60)
Eighteen new polymorphic markers in the multiple endocrine neoplasia type 1 (MEN1) region (1997) (60)
Pathologic complete response after preoperative anti-HER2 therapy correlates with alterations in PTEN, FOXO, phosphorylated Stat5, and autophagy protein signaling (2013) (60)
Reduction of tumour cell entry into vessels by BCG-activated macrophages. (1977) (60)
Correlation of molecular effects and pathologic complete response to preoperative lapatinib and trastuzumab, separately and combined prior to neoadjuvant breast cancer chemotherapy. (2011) (60)
A Transforming Growth Factor-β Receptor–Interacting Protein Frequently Mutated in Human Ovarian Cancer (2005) (59)
Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo (2004) (59)
Reverse-Phase Phosphoproteome Analysis of Signaling Pathways Induced by Rift Valley Fever Virus in Human Small Airway Epithelial Cells (2010) (59)
Drosophila screening model for metastasis: Semaphorin 5c is required for l(2)gl cancer phenotype (2003) (59)
Cancer Proteomics: The State of the Art (2002) (59)
Proteomic approaches in cancer risk and response assessment. (2004) (58)
Type IV collagen stimulates an increase in intracellular calcium. Potential role in tumor cell motility. (1992) (58)
Degradation of laminin by human tumor cathepsin B (1989) (58)
Nanoparticles: potential biomarker harvesters. (2006) (58)
The Use of Nanotrap Particles Technology in Capturing HIV-1 Virions and Viral Proteins from Infected Cells (2014) (58)
A phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: potential efficacy of the combination and demonstration of pharmacokinetic interaction. (2001) (57)
Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis (2014) (57)
Stochastic model of metastases formation. (1976) (57)
Immunodetection of the metastasis-associated laminin receptor in human breast cancer cells obtained by fine-needle aspiration biopsy. (1990) (57)
Concentration and preservation of very low abundance biomarkers in urine, such as human growth hormone (hGH), by Cibacron Blue F3G-A loaded hydrogel particles (2008) (56)
Genetic changes associated with primary Merkel cell carcinoma. (1998) (56)
Signal pathway profiling of epithelial and stromal compartments of colonic carcinoma reveals epithelial-mesenchymal transition (2008) (56)
Molecular Analysis of Synchronous Uterine and Ovarian Endometrioid Tumors (1997) (56)
Metalloproteinases and malignant conversion: does correlation imply causality? (1989) (56)
The role of tissue microdissection in cancer research. (2001) (56)
Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization. (1999) (56)
The heme degradation pathway is a promising serum biomarker source for the early detection of Alzheimer's disease. (2010) (56)
Mechanisms of cancer invasion and metastasis. (1985) (55)
cDNA sequencing and analysis of POV1 (PB39): a novel gene up-regulated in prostate cancer. (1998) (55)
Site-directed mutations in the tumor-associated cytokine, autotaxin, eliminate nucleotide phosphodiesterase, lysophospholipase D, and motogenic activities. (2003) (55)
Sulfatide-binding domain of the laminin A chain. (1990) (55)
The role of calcium in the regulation of invasion and angiogenesis. (1996) (55)
Immunohistochemical study of matrix metalloproteinases and their tissue inhibitors in pulmonary Langerhans' cell granulomatosis. (1997) (55)
A novel biomarker harvesting nanotechnology identifies Bak as a candidate melanoma biomarker in serum (2011) (55)
Extraction of type‐IV collagenase/gelatinase from plasma membranes of human cancer cells (1990) (55)
Proteomic analysis of human breast cancer tissue with laser-capture microdissection and reverse-phase protein microarrays. (2004) (54)
High-resolution serum proteomic patterns for ovarian cancer detection (2004) (54)
Direct Diagnostic Tests for Lyme Disease (2018) (53)
Investigation of the Ovarian and Prostate Cancer Peptidome for Candidate Early Detection Markers Using a Novel Nanoparticle Biomarker Capture Technology (2010) (53)
Tumor invasion and metastases: role of the basement membrane. Warner-Lambert Parke-Davis Award lecture. (1984) (53)
Expression Microdissection: Operator-Independent Retrieval of Cells for Molecular Profiling (2004) (52)
Invasiveness and ploidy of human mammary carcinomas in short-term culture. (1985) (52)
In vivo monitoring of the death rate of artificial murine pulmonary micrometastases. (1978) (51)
Quantum dots for biomedical applications. (2008) (50)
Reverse Transcription‐Polymerase Chain Reaction Phenotyping of Metalloproteinases and Inhibitors Involved in Tumor Matrix Invasion (1993) (50)
Phosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samples. (2011) (50)
Differential proteolytic susceptibility of laminin alpha and beta subunits. (1982) (50)
A systems biology approach to the pathogenesis of obesity‐related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis (2007) (50)
The topological requirements for robust perfect adaptation in networks of any size (2018) (49)
Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma. (2001) (49)
System dynamics of metastatic process from an implanted tumor. (1976) (49)
Multiplexed cell signaling analysis of metastatic and nonmetastatic colorectal cancer reveals COX2-EGFR signaling activation as a potential prognostic pathway biomarker. (2009) (49)
Sensitivity of N-nitrosomethylurea-induced rat mammary tumors to cis-hydroxyproline, an inhibitor of collagen production. (1981) (49)
von Hippel-Lindau disease gene deletion detected in microdissected sporadic human colon carcinoma specimens. (1996) (48)
p21waf1/cip1 and transforming growth factor beta 1 protein expression correlate with survival in non-small cell lung cancer. (1998) (47)
Cytoskeletal agents inhibit motility and adherence of human tumor cells. (1993) (47)
Stimulation and regulation of tumor cell motility in invasion and metastasis. (1995) (47)
An improved method for construction of directionally cloned cDNA libraries from microdissected cells. (1998) (47)
Protein painting reveals solvent-excluded drug targets hidden within native protein–protein interfaces (2014) (47)
Functional Protein Network Activation Mapping Reveals New Potential Molecular Drug Targets for Poor Prognosis Pediatric BCP-ALL (2010) (47)
Identification of type IV collagenase in rat testicular cell culture: influence of peritubular-Sertoli cell interactions. (1990) (47)
Endothelialization of embolized tumor cells during metastasis formation (2005) (46)
Lectin-binding domains on laminin. (1983) (46)
Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma. (2005) (46)
Emerging concepts in biomarker discovery; The US-Japan workshop on immunological molecular markers in oncology (2009) (46)
Human melanoma cell invasion is inhibited in vitro by swainsonine and deoxymannojirimycin with a concomitant decrease in collagenase IV expression (1991) (45)
Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using anin vitro Matrigel model (2005) (45)
Reverse-phase protein microarrays for theranostics and patient tailored therapy. (2009) (45)
Laser capture microdissection for protein and NanoString RNA analysis. (2013) (45)
Cancer: Checkpoint for invasion (2000) (45)
Inhibition of human type IV collagenase by a highly conserved peptide sequence derived from its prosegment. (1991) (45)
Cell motility, a principal requirement for metastasis. (1991) (45)
Induction of tissue‐type plasminogen activator and 72‐kDa type‐IV collagenase by ionizing radiation in rat astrocytes (1994) (45)
Proteomic analysis at the bedside: early detection of cancer. (2002) (44)
Necropsy as a research method in the age of molecular pathology (1995) (44)
The use of hydrogel microparticles to sequester and concentrate bacterial antigens in a urine test for Lyme disease. (2011) (44)
Gelatin-degrading type IV collagenase isolated from human small cell lung cancer. (1989) (44)
A serum proteomic approach to gauging the state of remission in Wegener's granulomatosis. (2005) (43)
Identification of a novel transcript up-regulated in a clinically aggressive prostate carcinoma. (1997) (43)
Application of Nanotrap technology for high sensitivity measurement of urinary outer surface protein A carboxyl-terminus domain in early stage Lyme borreliosis (2015) (43)
Proteomic analysis for early detection of ovarian cancer: A realistic approach? (2003) (43)
L-histidine inhibits production of lysophosphatidic acid by the tumor-associated cytokine, autotaxin (2005) (43)
SELDI-TOF mass spectrometry for cancer biomarker discovery and serum proteomic diagnostics. (2005) (43)
Bcl-2 immunohistochemistry in a surgical series of non-small cell lung cancer patients. (1998) (42)
Tumor extracellular matrix. (1982) (42)
Role of the Extracellular Matrix in Cancer (1985) (42)
A Role for the Laminin Receptor in Leukocyte Chemotaxis (1987) (42)
Analysis of recurrent germline mutations in the MEN1 gene encountered in apparently unrelated families (1998) (42)
Two phases of pseudopod protrusion in tumor cells revealed by a micropipette. (1994) (42)
Glioblastoma cell enrichment is critical for analysis of phosphorylated drug targets and proteomic-genomic correlations. (2014) (41)
IL-1 Family Cytokines Use Distinct Molecular Mechanisms to Signal through Their Shared Co-receptor. (2017) (41)
The role of the extracellular matrix in tumor cell metastasis. (1994) (41)
Systems Analysis of the NCI-60 Cancer Cell Lines by Alignment of Protein Pathway Activation Modules with “-OMIC” Data Fields and Therapeutic Response Signatures (2013) (41)
Improved data normalization methods for reverse phase protein microarray analysis of complex biological samples. (2012) (40)
Laminin-dependent and laminin-independent adhesion of human melanoma cells to sulfatides. (1988) (40)
Kinase substrate protein microarray analysis of human colon cancer and hepatic metastasis. (2005) (40)
AMPK inhibition enhances apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cells (2013) (39)
Proteomic analysis of pancreatic ductal adenocarcinoma cells reveals metabolic alterations. (2011) (39)
A possible role for cysteine proteinase and its inhibitors in motility of malignant melanoma and other tumour cells (1992) (39)
Binding domain for laminin on type IV collagen. (1985) (39)
Use of a Novel Chagas Urine Nanoparticle Test (Chunap) for Diagnosis of Congenital Chagas Disease (2014) (39)
Activated VEGF receptor shed into the vitreous in eyes with wet AMD: a new class of biomarkers in the vitreous with potential for predicting the treatment timing and monitoring response. (2009) (39)
Karyotypic analysis of diploid or near diploid metastatic Harvey ras transformed rat embryo fibroblasts. (1986) (39)
Development of multiplexed protein profiling and detection using near infrared detection of reverse-phase protein microarrays (2004) (39)
Serum S100A6 Concentration Predicts Peritoneal Tumor Burden in Mice with Epithelial Ovarian Cancer and Is Associated with Advanced Stage in Patients (2009) (38)
Lysophosphatidic Acid Down-Regulates Stress Fibers and Up-Regulates Pro–Matrix Metalloproteinase-2 Activation in Ovarian Cancer Cells (2007) (38)
Interferon enhancement of the invasive capacity of Ewing sarcoma cells in vitro. (1982) (38)
p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer. (1998) (38)
Protein pathway activation mapping of brain metastasis from lung and breast cancers reveals organ type specific drug target activation. (2011) (38)
IDENTIFICATION OF MICROMETASTASIS OF BREAST CARCINOMAS BY PRESENCE OF BASEMENT MEMBRANE COLLAGEN (1979) (38)
Identification of a new immunoglobulin superfamily protein expressed in blood vessels with a heparin-binding consensus sequence. (1995) (37)
Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene. (1997) (37)
Cellular and metabolic specificity in the interaction of adhesion proteins with collagen and with cells. (1979) (37)
In vitro quantitative assay of invasion using human amnion (1982) (37)
Role of oncogenes in metastases. (1988) (36)
Ebola Virus VP40 Modulates Cell Cycle and Biogenesis of Extracellular Vesicles (2018) (36)
The Sustained Induction of c-MYC Drives Nab-Paclitaxel Resistance in Primary Pancreatic Ductal Carcinoma Cells (2019) (36)
Purification of a gelatin-degrading type IV collagenase secreted by ras oncogene-transformed fibroblasts. (1988) (36)
Opportunities for Nanotechnology-Based Innovation in Tissue Proteomics (2004) (36)
Laser Capture Microdissection: Beyond Functional Genomics to Proteomics (2000) (36)
Increased type IV collagenase in lgl-induced invasive tumors of Drosophila. (1994) (36)
HTLV-1 Extracellular Vesicles Promote Cell-to-Cell Contact (2019) (36)
Reverse phase protein microarrays for monitoring biological responses. (2007) (35)
The gene for multiple endocrine neoplasia type 1: recent findings. (1999) (35)
Protein synthesis but not DNA synthesis is required for tumor cell invasion in vitro. (1984) (35)
Type IV collagenase/gelatinase (MMP-2) is not increased in plasma of patients with cancer. (1992) (35)
Somatic mutations of the MEN1 tumor suppressor gene detected in sporadic angiofibromas. (1998) (34)
Biochemical mechanisms involved in tumor cell penetration of the basement membrane (1982) (34)
Reverse-phase protein microarrays for tissue-based analysis. (2005) (34)
Fractionation of serum components using nanoporous substrates. (2006) (34)
Putting the "bio" back into biomarkers: orienting proteomic discovery toward biology and away from the measurement platform. (2008) (34)
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356 (2016) (33)
Use of proteomic patterns to screen for gastrointestinal malignancies. (2004) (33)
Discovery of Mouse Spleen Signaling Responses to Anthrax using Label-Free Quantitative Phosphoproteomics via Mass Spectrometry* (2010) (33)
Elevated TNFR1 and Serotonin in Bone Metastasis Are Correlated with Poor Survival following Bone Metastasis Diagnosis for Both Carcinoma and Sarcoma Primary Tumors (2013) (33)
Plasminogen activators (urokinase) mediate neovascularization: possible role in tumor angiogenesis. (1986) (33)
Adhere, Degrade, and Move: The Three-Step Model of Invasion. (2016) (32)
Stromal therapy: the next step in ovarian cancer treatment. (2002) (32)
The role of genomics and proteomics: technologies in studying non-alcoholic fatty liver disease. (2007) (32)
Nucleoside diphosphate kinases, nm23, and tumor metastasis: possible biochemical mechanisms. (1992) (32)
Cancer cells, components of basement membranes, and proteolytic enzymes. (1985) (32)
Method for quantitating tumor cell removal and tumor cell-invasive capacity in experimental metastases. (1977) (32)
Tumour motility factors. (1988) (32)
Pilot phase I/II personalized therapy trial for metastatic colorectal cancer: evaluating the feasibility of protein pathway activation mapping for stratifying patients to therapy with imatinib and panitumumab. (2014) (32)
Individualized therapy for metastatic colorectal cancer (2013) (31)
Abortion in mice induced by intravenous injections of antibodies to type IV collagen or laminin. (1983) (31)
Proceedings of a National Cancer Institute workshop: MR spectroscopy and tumor cell biology. (1992) (31)
Editorial :Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). DOI: 10.1080/15548627.2015.1100356;WOS:000373595400001; 2-s2.0-85013763791&;PMID: 26799652 (2016) (31)
Phosphoprotein stability in clinical tissue and its relevance for reverse phase protein microarray technology. (2011) (30)
Quantitation of basement membrane collagen degradation by living tumor cells in vitro. (1980) (30)
Improved reproducibility of reverse‐phase protein microarrays using array microenvironment normalization (2009) (30)
Comparison of global versus epidermal growth factor receptor pathway profiling for prediction of lapatinib sensitivity in bladder cancer. (2009) (30)
Monitoring Proteins and Protein Networks Using Reverse Phase Protein Arrays (2010) (30)
The laminin receptor and basement membrane dissolution: role in tumour metastasis. (2008) (30)
Impact of upfront cellular enrichment by laser capture microdissection on protein and phosphoprotein drug target signaling activation measurements in human lung cancer: Implications for personalized medicine (2015) (30)
Biophysical Characterization of gp41 Aggregates Suggests a Model for the Molecular Mechanism of HIV-associated Neurological Damage and Dementia* (2000) (30)
A control theoretic paradigm for cell signaling networks: a simple complexity for a sensitive robustness. (2006) (30)
General keynote: proteomic patterns in sera serve as biomarkers of ovarian cancer. (2003) (29)
Application of laser microdissection and reverse-phase protein microarrays to the molecular profiling of cancer signal pathway networks in the tissue microenvironment. (2009) (29)
Vascular tumors produced by NIH/3T3 cells transfected with human AIDS Kaposi's sarcoma DNA. (1985) (29)
The spectra count label-free quantitation in cancer proteomics. (2012) (29)
Development of reverse phase protein microarrays for clinical applications and patient-tailored therapy. (2007) (29)
Invasion and Metastasis (2007) (28)
Review Article: Biology of Melanoma Invasion and Metastasis (1987) (28)
p53 mutations and occupational exposures in a surgical series of lung cancers. (1996) (28)
Laser Capture Microdissection (2005) (28)
Mass spectrometry-based protein biomarker discovery: solving the remaining challenges to reach the promise of clinical benefit. (2010) (28)
Cancer metabolism and mass spectrometry-based proteomics. (2015) (28)
Clinical Proteomics for Cancer Biomarker Discovery and Therapeutic Targeting (2002) (27)
The use of Nanotrap particles for biodefense and emerging infectious disease diagnostics (2014) (27)
Characteristics of invasive and noninvasive human colorectal adenocarcinoma cells. (1990) (27)
Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumors (2015) (27)
Phosphoproteomic biomarkers predicting histologic nonalcoholic steatohepatitis and fibrosis. (2010) (27)
Biochemical mechanisms of tumor invasion and metastasis. (1987) (27)
Microdissection, microchip arrays, and molecular analysis of tumor cells (primary and metastases). (1998) (27)
Supra-additive growth inhibition by a celecoxib analogue and carboxyamido-triazole is primarily mediated through apoptosis. (2005) (27)
Multi-step cascade of tumor cell metastasis. (1992) (27)
Exploiting Radiation-Induced Signaling to Increase the Susceptibility of Resistant Cancer Cells to Targeted Drugs: AKT and mTOR Inhibitors as an Example (2017) (27)
Laser capture microdissection: Arcturus(XT) infrared capture and UV cutting methods. (2012) (26)
Cancer biomarkers: closer to delivering on their promise. (2011) (26)
Adherence and regulation of leukotaxis. (1983) (26)
Use of a cyclo-oxygenase type-2-selective non-steroidal anti-inflammatory agent to prevent preterm delivery (1997) (26)
Profiling of normal human leg lymph proteins using the 2-D electrophoresis and SELDI-TOF mass spectrophotometry approach. (2004) (26)
Nanoparticle technology: amplifying the effective sensitivity of biomarker detection to create a urine test for hGH. (2009) (26)
A Pilot Characterization of Human Lung NSCLC by Protein Pathway Activation Mapping (2012) (26)
Cancer proteomics: many technologies, one goal (2005) (26)
Cyclocreatine inhibits stimulated motility in tumor cells possessing creatine kinase (1998) (25)
Tumor cell motility. (1991) (25)
Reverse phase protein microarrays for theranostics and patient-tailored therapy. (2008) (25)
Degradation of basement membrane components by vascular endothelial cells: role in neovascularization. (2008) (25)
Affinity enrichment for mass spectrometry: improving the yield of low abundance biomarkers (2018) (25)
Use of Stem Cell Extracellular Vesicles as a “Holistic” Approach to CNS Repair (2020) (25)
Granulocyte‐macrophage colony‐stimulating factor induces human melanoma‐cell migration (2009) (25)
Influence of Tumor Development on the Host (1989) (24)
Development of a novel proteomic approach for mitochondrial proteomics from cardiac tissue from patients with atrial fibrillation. (2011) (24)
Structure, function, and pathology of basement membranes. (1983) (24)
AAMP, a conserved protein with immunoglobulin and WD40 domains, regulates endothelial tube formation in vitro. (1996) (24)
The role of cellular proteases and their inhibitors in invasion and metastasis. Introductionary overview. (1990) (24)
Anthrax infection inhibits the AKT signaling involved in the E-cadherin-mediated adhesion of lung epithelial cells (2009) (24)
The role of autotaxin and other motility stimulating factors in the regulation of tumor cell motility. (1993) (24)
Automated laser capture microdissection for tissue proteomics. (2008) (23)
Reverse-phase protein microarrays (RPPA) as a diagnostic and therapeutic guide in multidrug resistant leukemia. (2011) (23)
Expression of type IV collagenase correlates with the invasion of human lymphoblastoid cell lines and pathogenesis in SCID mice. (1992) (23)
Mapping protein signal pathway interaction in sarcoma bone metastasis: linkage between rank, metalloproteinases turnover and growth factor signaling pathways (2013) (23)
Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy (2010) (23)
Reverse phase protein microarrays for clinical applications. (2011) (23)
Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: Implications for personalized cancer therapy (2015) (23)
Biochemistry and Molecular Genetics of Cancer Metastasis (1986) (23)
Pilot and feasibility study: prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways (2012) (22)
Laminin inhibits the adhesion of a murine tumor of macrophage origin. (1982) (22)
Network-targeted combination therapy : a new concept in cancer treatment (2004) (22)
Stem Cell Extracellular Vesicles and their Potential to Contribute to the Repair of Damaged CNS Cells (2019) (22)
Purification and characterization of a connective-tissue-degrading metalloproteinase from the cytosol of metastatic melanoma cells. (1987) (22)
Inhibition of histone deacetylase 4 increases cytotoxicity of docetaxel in gastric cancer cells (2014) (22)
High CerS5 expression levels associate with reduced patient survival and transition from apoptotic to autophagy signalling pathways in colorectal cancer (2014) (22)
Autotaxin is an N linked glycoprotein but the sugar moieties are not needed for its stimulation of cellular motility (1995) (22)
Integrin alphavbeta3 mediates chemotactic and haptotactic motility in human melanoma cells through different signaling pathways. (1996) (22)
Degradation of glycoprotein and collagenous components of the basement membrane: studies with urokinase-type plasminogen activator, alpha-thrombin, and plasmin. (1986) (21)
Use of a Chagas Urine Nanoparticle Test (Chunap) to Correlate with Parasitemia Levels in T. cruzi/HIV Co-infected Patients (2016) (21)
Nanotechnology in clinical proteomics. (2007) (21)
Antibodies to collagenase‐resistant terminal regions of pro‐type IV collagen recognize whole basement membrane and 7 S collagen (1981) (21)
Modeling of protein signaling networks in clinical proteomics. (2005) (21)
Chromosome 16 allelic loss analysis of a large set of microdissected prostate carcinomas. (1999) (21)
Development of a novel substrate capture immunoassay for the detection of a neutral metalloproteinase capable of degrading basement membrane (type IV) collagen. (1990) (21)
Molecular network analysis using reverse phase protein microarrays for patient tailored therapy. (2008) (21)
Cancer metabolism: what we can learn from proteomic analysis by mass spectrometry. (2012) (20)
TIMP-2: identification and characterization of a new member of the metalloproteinase inhibitor family. (1992) (20)
The capsule surrounding primary liver tumors: Wherefrom its prognostic significance? (1990) (20)
Interactions of tumor cells with whole basement membrane in the presence or absence of endothelium. (1982) (20)
Reverse phase protein microarrays: fluorometric and colorimetric detection. (2011) (20)
Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread (2017) (20)
Altered Gene Expression in Tumor Metastasis: The nm23 Gene (1989) (20)
Promising directions for the diagnosis and management of gynecological cancers (2003) (20)
-Omics and Cancer Biomarkers: Link to the Biological Truth or Bear the Consequences (2012) (20)
Glia Maturation Factor Gamma (GMFG): A Cytokine-Responsive Protein During Hematopoietic Lineage Development and Its Functional Genomics Analysis (2006) (20)
A method for the selective isolation and enrichment of carrier protein‐bound low‐molecular weight proteins and peptides in the blood (2007) (19)
Correlation of tumorigenicity with resistance to growth inhibition by cis-hydroxypyroline. (1979) (19)
Protease susceptibilities of HMW, 1α, 2α, but not 3α cartilage collagens are similar to type V collagen (1982) (19)
APPLICATION OF LASER CAPTURE MICRODISSECTION AND PROTEIN MICROARRAY TECHNOLOGIES IN THE MOLECULAR ANALYSIS OF AIRWAY INJURY FOLLOWING POLLUTION PARTICLE EXPOSURE (2004) (19)
Biosynthesis of type IV and V (alpha A-alpha B) collagens by human placenta. (1981) (18)
Beyond the genome to tissue proteomics (1999) (18)
Identification and characterization of endogenous Langerin ligands in murine extracellular matrix. (2006) (18)
Novel Approaches to Visualization and Data Mining Reveals Diagnostic Information in the Low Amplitude Region of Serum Mass Spectra from Ovarian Cancer Patients (2004) (18)
Comparison of autocrine mechanisms promoting motility in two metastatic cell lines: Human melanoma and ras‐transfected NIH3T3 cells (1991) (18)
Gene products which play a role in cancer invasion and metastasis (1988) (18)
H-ras p21 and the metastatic phenotype. (1988) (18)
Clinical proteomics: application at the bedside. (2004) (18)
An Interventional Magnetic Resonance Imaging Technique for the Molecular Characterization of Intraprostatic Dynamic Contrast Enhancement (2005) (18)
Drosophila Invasive Tumors: A Model for Understanding Metastasis (2004) (18)
Tumor autocrine motility factor. (1986) (17)
Stimulation of retinoic acid of synthesis and turnover of basement membrane in mouse embryonal carcinoma-derived endoderm cells. (1982) (17)
Breast cancer stem cells: a new target for therapy. (2011) (17)
Butyrate induced reduction of tumor cell laminin receptors. (1986) (17)
Role of type IV collagenases in human breast cancer. (1992) (17)
Differentiation of tumour‐stage mycosis fungoides, psoriasis vulgaris and normal controls in a pilot study using serum proteomic analysis (2007) (17)
Thrombin Cleavage of Extracellular Matrix Proteins (1986) (17)
Molecular biology of metastases: a review of recent approaches. (1986) (17)
Development of acquired resistance to lapatinib may sensitise HER2-positive breast cancer cells to apoptosis induction by obatoclax and TRAIL (2018) (17)
Proteomic patterns in serum and identification of ovarian cancer (2002) (16)
Basement membranes in human cancer. (1986) (16)
Protein pathway activation mapping of colorectal metastatic progression reveals metastasis-specific network alterations (2013) (16)
Tumor autocrine motility factors. (1988) (16)
Biochemical mechanisms of tumor invasion and metastases. (1988) (16)
Protein Microarray Analysis of Mammary Epithelial Cells from Obese and Nonobese Women at High Risk for Breast Cancer: Feasibility Data (2011) (16)
Extracellular vesicles from HTLV-1 infected cells modulate target cells and viral spread (2021) (16)
Microdissection-based genetic discovery and analysis applied to cancer progression. (1997) (16)
Characterization of a laminin receptor from human breast carcinoma tissue (2005) (16)
Biology of melanoma invasion and metastasis. (1987) (16)
Virtual reality and augmented reality: Advances in surgery (2017) (16)
Blasting into the Microworld of Tissue Proteomics: A New Window on Cancer (2004) (16)
Synthesis and characterization of hydrogel particles containing Cibacron Blue F3G-A. (2010) (16)
Micrometastases formation: a probabilistic model. (1977) (16)
Profiling the activity of G proteins in patient‐derived tissues by rapid affinity‐capture of signal transduction proteins (GRASP) (2004) (15)
Pathology-Driven Comprehensive Proteomic Profiling of the Prostate Cancer Tumor Microenvironment (2017) (15)
Augmented Reality Imaging System: 3D Viewing of a Breast Cancer. (2016) (15)
Utilization of Proteomic Technologies for Precision Oncology Applications. (2019) (15)
Identification of novel candidate circulating biomarkers for malignant soft tissue sarcomas: Correlation with metastatic progression (2016) (15)
AAMP, a newly identified protein, shares a common epitope with alpha-actinin and a fast skeletal muscle fiber protein. (1996) (15)
Blocking basement membrane collagen deposition inhibits the growth of 7,12-dimethylbenzanthracene-induced rat mammary tumors. (1981) (15)
New Approaches to Molecular Profiling of Tissue Samples (2000) (15)
Proteomic Analysis Reveals Autophagy as Pro-Survival Pathway Elicited by Long-Term Exposure with 5-Azacitidine in High-Risk Myelodysplasia (2017) (15)
Detection of the von Hippel-Lindau gene deletion in cytologic specimens using microdissection and the polymerase chain reaction. (1994) (15)
A novel method for selection of invasive tumor cells: Derivation and characterization of highly metastatic K1735 melanoma cell lines based onin vitro andin vivo invasive capacity (1988) (15)
A preclinical evaluation of the MEK inhibitor refametinib in HER2-positive breast cancer cell lines including those with acquired resistance to trastuzumab or lapatinib (2017) (15)
Discovery of Infectious Disease Biomarkers in Murine Anthrax Model Using Mass Spectrometry of the Low-Molecular-Mass Serum Proteome (2009) (15)
Anti-laminin receptor antibody targeting of liposomes with encapsulated doxorubicin to human breast cancer cells in vitro. (1989) (15)
Analysis of the Babesia microti proteome in infected red blood cells by a combination of nanotechnology and mass spectrometry. (2019) (15)
An Omics Approach to Extracellular Vesicles from HIV-1 Infected Cells (2019) (14)
Invasion and metastasis: new approaches to an old problem. (1993) (14)
Laminin expression by human pancreatic carcinoma cells in the nude mouse and in culture. (1987) (14)
Application of physicochemically modified silicon substrates as reverse-phase protein microarrays. (2009) (14)
Introductionary overview (1990) (14)
Regulatory approval pathways for molecular diagnostic technology. (2012) (14)
Biochemistry of bladder cancer invasion and metastasis. Clinical implications. (1992) (14)
Effects of HER Family–targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer (2020) (14)
Boundaries between Promotion and Progression during Carcinogenesis (2012) (14)
Rapamycin modulation of p70 S6 kinase signaling inhibits Rift Valley fever virus pathogenesis (2017) (14)
A sensitive screening assay for secreted motility-stimulating factors. (2000) (14)
Recognition of Multiple Classes of Hepatitis C Antibodies Increases Detection Sensitivity in Oral Fluid (2001) (14)
Angiogenesis: Isolation of a protein that stimulates blood vessel growth (1985) (13)
A pilot study exploring the molecular architecture of the tumor microenvironment in human prostate cancer using laser capture microdissection and reverse phase protein microarray (2016) (13)
Selective Inhibition of Mitogen-induced Transactivation of the HIV Long Terminal Repeat by Carboxyamidotriazole (1997) (13)
Cofilin hyperactivation in HIV infection and targeting the cofilin pathway using an anti-α4β7 integrin antibody (2019) (13)
Pure yolk sac carcinoma of the mouse uterus: report of 8 cases. (1984) (13)
Analysis of urinary human growth hormone (hGH) using hydrogel nanoparticles and isoform differential immunoassays after short recombinant hGH treatment: preliminary results. (2013) (13)
The Warburg Effect and Mass Spectrometry-based Proteomic Analysis. (2017) (13)
Nitric oxide as a regulator of B. anthracis pathogenicity (2015) (13)
Type IV collagenase activity of a primary HSV‐2‐induced hamster fibrosarcoma and its in vivo metastases and in vitro clones (1987) (13)
Cloning and characterization of a novel human cDNA that has DNA similarity to the conserved region of the collagenase gene family. (1992) (13)
Dynamic Protein Pathway Activation Mapping of Adipose-Derived Stem Cell Differentiation Implicates Novel Regulators of Adipocyte Differentiation (2013) (13)
11q13 allelotype analysis in 27 northern American MEN1 kindreds identifies two distinct founder chromosomes. (1998) (13)
Dilution of protein gel stain results in retention of staining capacity. (2003) (13)
Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance (Proceedings of the National Academy of Sciences of the United States of America (2007) 104, 41 (16158-16163)) (2007) (13)
A wireless Internet application for healthcare (2001) (13)
Potential anti‐cancer activity of 7‐O‐pentyl quercetin: Efficient, membrane‐targeted kinase inhibition and pro‐oxidant effect (2017) (12)
Mechanism of Bacillus Calmette-Guérin-induced suppression of metastases in a poorly immunogenic fibrosarcoma. (1976) (12)
Augmented sparse reconstruction of protein signaling networks. (2007) (12)
Detection of gene deletion in single metastatic tumour cells in lymphnode tissue by fluorescent in-situ hybridisation (1997) (12)
Protein pathway activation associated with sustained virologic response in patients with chronic hepatitis C treated with pegylated interferon (PEG-IFN) and ribavirin (RBV). (2011) (12)
Cultured tumor cells produce chemotactic factors specific for endothelial cells: a possible mechanism for tumor-induced angiogenesis. (1983) (12)
Type IV collagenolytic activity linkage with the metastatic phenotype induced by ras transfection. (1988) (12)
Linkage analysis demonstrates that the Timp-2 locus is on mouse chromosome 11. (1992) (11)
Protein Phosphatase 1α Interacts with Venezuelan Equine Encephalitis Virus Capsid Protein and Regulates Viral Replication through Modulation of Capsid Phosphorylation (2018) (11)
Clinical Application of Proteomics in Ovarian Cancer Prevention and Treatment (2012) (11)
Immunoreactivity in malignant mesotheliomas with antibodies to basement membrane components and their receptors. (1990) (11)
Role of km23-1 in RhoA/actin-based cell migration. (2012) (11)
Whole Proteome Analysis of Mouse Lymph Nodes in Cutaneous Anthrax (2014) (11)
Mathematical modeling of the cancer cell’s control circuitry : paving the way to individualized therapeutic strategies (2007) (11)
MS analysis reveals O‐methylation of L‐lactate dehydrogenase from pancreatic ductal adenocarcinoma cells (2012) (11)
Hydrogel nanoparticle harvesting of plasma or urine for detecting low abundance proteins. (2014) (11)
Unlocking the secrets to protein–protein interface drug targets using structural mass spectrometry techniques (2015) (11)
Tumor cell attachment and degradation of basement membranes. (1983) (10)
Occurrence and distribution of matrix metalloproteinase-2-immunoreactivity in human embryonic tissues. (1995) (10)
Protein painting, an optimized MS-based technique, reveals functionally relevant interfaces of the PD-1/PD-L1 complex and the YAP2/ZO-1 complex (2019) (10)
Interaction of Tumor Cells with the Basement Membrane of Endothelium (1984) (10)
Attacking Breast Cancer at the Preinvasion Stage by Targeting Autophagy (2013) (10)
D3D augmented reality imaging system: proof of concept in mammography (2016) (10)
Application of Analyte Harvesting Nanoparticle Technology to the Measurement of Urinary HGH in Healthy Individuals. (2012) (10)
Protein drug target activation homogeneity in the face of intra-tumor heterogeneity: implications for precision medicine (2016) (10)
Extraction of type IV collagenase/gelatinase from plasma membranes of human pancreatic cancer cells. (1992) (10)
Quantitation of human plasma levels of the anticancer agent carboxyamidotriazole by high-performance liquid chromatography. (1993) (10)
Gangliosides indirectly inhibit the binding of laminin to sulfatides. (1986) (10)
A transforming growth factor-beta receptor-interacting protein frequently mutated in human ovarian cancer. (2005) (10)
Nucleotide binding to autotaxin: crosslinking of bound substrate followed by lysC digestion identifies two labeled peptides. (1997) (10)
A Functional Polymorphism in RGS 6 Modulates the Risk of Bladder Cancer (2004) (10)
Identification and partial characterization of a low-molecular-weight inhibitor of leukotaxis from fibrosarcoma cells. (1984) (10)
RPPA: Origins, Transition to a Validated Clinical Research Tool, and Next Generations of the Technology. (2019) (9)
Fibronectin-based masking molecule blocks platelet adhesion. (2003) (9)
A pilot study utilizing molecular profiling to find potential targets and select individualized treatments for patients with metastatic breast cancer. (2013) (9)
Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection (2020) (9)
Kinase-driven metabolic signalling as a predictor of response to carboplatin–paclitaxel adjuvant treatment in advanced ovarian cancers (2017) (9)
Molecular profiling of cancer and drug-induced toxicity using new proteomic technologies (2001) (9)
A new model isolates glioblastoma clonal interactions and reveals unexpected modes for regulating motility, proliferation, and drug resistance (2019) (9)
Stratification of clear cell renal cell carcinoma by signaling pathway analysis (2014) (9)
Seropositivity of COVID-19 among asymptomatic healthcare workers: A multi-site prospective cohort study from Northern Virginia, United States (2021) (9)
Proteomic Technologies to Study Diseases of the Lymphatic Vascular System (2002) (9)
Chemokine-Releasing Nanoparticles for Manipulation of the Lymph Node Microenvironment (2015) (9)
Nanoparticle technology: Addressing the fundamental roadblocks to protein biomarker discovery. (2009) (9)
Stromal TRIM28-associated signaling pathway modulation within the colorectal cancer microenvironment (2018) (9)
Overview of Metastasis Assays (2001) (9)
A phase II clinical trial with proteomic profiling of imatinib mesylate in patients with refractory or relapsed epithelial ovarian cancer (EOC). (2004) (9)
Ductal carcinoma in situ: challenges, opportunities, and uncharted waters. (2012) (9)
Alterations of p 14 ARF , p 53 , and p 73 Genes Involved in the E 2 F-1-mediated Apoptotic Pathways in Non-Small Cell Lung Carcinoma (2001) (8)
Erratum: Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse (Cancer Cell (4) (437-450)) (2004) (8)
A pilot study exploring the molecular architecture of the tumor microenvironment in human prostate cancer using laser capture microdissection and reverse phase protein microarray. (2016) (8)
Identification and characterization of differentially expressed genes in tumor metastasis: the nm23 gene. (1991) (8)
Synthesis of pro-collagen type II by a xenotransplanted human chondroblastic osteosarcoma. (1981) (8)
Loss of heterozygosity on chromosome 11q13 in microdissected human male breast carcinomas. (1995) (8)
Regulation of the metastatic phenotype by the E1A gene of adenovirus-2. (1988) (8)
Collagen and laminin immunoreactivity in Ewing's sarcoma: support for an uncommitted mesenchymal cell derivation. (1986) (7)
Serum 99 th Percentile Reference Cutoffs for Seven Cardiac Troponin Assays (2004) (7)
Assay for radiolabeled type IV collagen in the presence of other proteins using a specific collagenase. (1980) (7)
Encouraging long‐term survival following autophagy inhibition using neoadjuvant hydroxychloroquine and gemcitabine for high‐risk patients with resectable pancreatic carcinoma (2021) (7)
New invasion assay using endothelial cells grown on native human basement membrane (1983) (7)
Proteomic analysis reveals pathogen-derived biomarkers of acute babesiosis in erythrocytes, plasma, and urine of infected hamsters (2020) (7)
Different measures of HMGB1 location in cancer immunology. (2019) (7)
Multiplexed protein signal pathway mapping identifies patients with rectal cancer that responds to neoadjuvant treatment. (2012) (7)
Probing the depths of degradation: matrix metalloproteinase-2 and endometrial menstrual breakdown. (1996) (7)
Mass spectrometry‐based characterization of the vitreous phosphoproteome (2010) (7)
Manual exfoliation of fresh tissue obviates the need for frozen sections for molecular profiling (2005) (7)
Lipoarabinomannan antigenic epitope differences in tuberculosis disease subtypes (2020) (6)
Reverse-Phase Microarray Analysis Reveals Novel Targets in Lymph Nodes of Bacillus anthracis Spore-Challenged Mice (2015) (6)
Oncogene induction of metastases. (1988) (6)
Chemokine-Releasing Microparticles Improve Bacterial Clearance and Survival of Anthrax Spore-Challenged Mice (2016) (6)
Critical dependence of blood-borne biomarker concentrations on the half-lives of their carrier proteins. (2008) (6)
Tumor-Draining Lymph Secretome En Route to the Regional Lymph Node in Breast Cancer Metastasis (2020) (6)
Molecular Profiling of Clinical Tissue Specimens (2000) (6)
Mass Spectrometry-Based Protein Biomarker Discovery and Measurement: Sensitivity is the Greatest Hurdle (2010) (6)
Trapping radioactive carbon dioxide during cellular metabolic assays under standard culture conditions: description of a unique gas-capturing device. (2004) (6)
Linking laboratory and clinical research: the development of molecularly targeted therapeutics inside the national cancer institute center for cancer research. (2003) (6)
Circulating Candidate Biomarkers in Giant Cell Tumors of Bone (2018) (6)
Unlocking bone for proteomic analysis and FISH (2019) (5)
Development of a hybrid alphavirus-SARS-CoV-2 pseudovirion for rapid quantification of neutralization antibodies and antiviral drugs (2022) (5)
Identification of functional tumor vessels by resorcin-crystal violet stain infusion. (1976) (5)
Clinical Utility of a Highly Sensitive Lateral Flow Immunoassay as determined by Titer Analysis for the Detection of anti-SARS-CoV-2 Antibodies at the Point-of-Care (2020) (5)
Tumor Cell Migration (2003) (5)
Evaluation of pathogen specific urinary peptides in tick-borne illnesses (2020) (5)
P5-13-03: Correlation of Clinical and Molecular Findings with Pathologic Response to Preoperative Lapatinib and Trastuzumab, Separately or in Combination, Prior to Neoadjuvant Chemotherapy for HER2 Positive Breast Cancer. (2011) (5)
Frequent post-operative monitoring of colorectal cancer using individualised ctDNA validated by multiregional molecular profiling (2021) (5)
Exosomes originating from infection with the cytoplasmic single-stranded RNA virus Rift Valley fever virus (RVFV) protect recipient cells by inducing RIG-I mediated IFN-B response that leads to activation of autophagy (2021) (5)
Growth autonomy: the only requirement for metastasis? (1988) (5)
Expression of oncogenes in cancer metastases. (1986) (5)
Multiplexed Cell Signaling Analysis of Metastatic and Nonmetastatic Colorectal Cancer Reveals COX2-EGFR Signaling Activation as a Potential Prognostic Pathway Biomarker. (2009) (5)
Laser Capture Proteomics: spatial tissue molecular profiling from the bench to personalized medicine (2021) (5)
Mass spectrometric analysis reveals O-methylation of pyruvate kinase from pancreatic cancer cells (2013) (5)
The aggregated form of an AAMP derived peptide behaves as a heparin sensitive cell binding agent. (1997) (5)
Molecular inhibition of cancer cell invasion and metastasis. (1991) (5)
Development of Nanoparticle-Enabled Protein Biomarker Discovery: Implementation for Saliva-Based Traumatic Brain Injury Detection (2015) (5)
PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine (2021) (4)
Discussion: Metastasis and Angiogenesis in Epithelial Ovarian Cancer (2003) (4)
Chloroquine enjoys a renaissance as an antineoplastic therapy (2013) (4)
Development of a novel hybrid alphavirus-SARS-CoV-2 particle for rapid in vitro screening and quantification of neutralization antibodies, viral variants, and antiviral drugs (2020) (4)
Clinical application of proteomics in ovarian cancer prevention and treatment. (2009) (4)
Abstract CT140: PINC trial: Preventing invasive breast neoplasia with chloroquine (2017) (4)
RESPONSE: Re: Serum Proteomic Patterns for Detection of Prostate Cancer (2003) (4)
Combination Kinase Inhibitor Treatment Suppresses Rift Valley Fever Virus Replication (2018) (4)
Proteomics of breast cancer (2006) (4)
Attachment of metastatic tumor cells to collagen (1982) (4)
Molecular Technologies for Personalized Cancer Management (2004) (4)
Biochemical mechanisms of tumor invasion and metastases. (1987) (4)
A Revolutionary approach to biomarker discovery (2006) (4)
Application of sector protein microarrays to clinical samples (2004) (4)
Tumor invasion and metastasis in the central nervous system (1986) (4)
Inventions and Patents: A Practical Tutorial. (2017) (4)
Cancer metastasis : experimental and clinical strategies : proceedings of a symposium held in Kalamazoo, Michigan, September 15-17, 1985 (1986) (4)
Esophageal Squamous Cell Cancer-Specific Protein Markers (2001) (3)
Microspheres Containing Cibacron Blue F3G-A and Incorporated Iron Oxide Nanoparticles as Biomarker Harvesting Platforms (2011) (3)
Invasión de células cancerosas y metástasis (1992) (3)
Detection of toxoplasmic encephalitis in HIV positive patients in urine with hydrogel nanoparticles (2020) (3)
Genetic Regulation of Invasion and Metastasis (2003) (3)
Phosphoproteomic Analysis of Pancreatic Ductal Adenocarcinoma Cells Reveals Differential Phosphorylation of Cell Adhesion, Cell Junction and Structural Proteins (2011) (3)
Multi-omic profiling of metastatic lesions to guide treatment selection: The Side Out 2 trial experience. (2018) (3)
THE ROLE OF TUMOR CELL-BASEMENT MEMBRANE INTERACTIONS IN THE METASTATIC PROCESS (1980) (3)
Comutation of PIK3CA and TP53 in Residual Disease After Preoperative Anti-HER2 Therapy in ERBB2 (HER2)-Amplified Early Breast Cancer. (2019) (3)
Inventions and patents: a practical tutorial. (2012) (3)
Genetic mechanisms in carcinogenesis and tumor progression : proceedings of a Genentech-UCLA Symposium held at Keystone, Colorado, January 21-27, 1989 (1990) (3)
Gelatinase-a/mmp-2 serum levels and neoplastic progression in breast-cancer patients. (1994) (3)
Genomic and Proteomic Pathway Mapping Reveals Signatures of Mesenchymal-Epithelial Plasticity in Inflammatory Breast Cancer (2011) (3)
Chapter 23. Collagenases in Tumor Cell Extravasation (1984) (3)
The state of the art microdissection and its downstream applications. (2000) (3)
Small business development for molecular diagnostics. (2012) (3)
Persistent CD49d engagement in circulating CLL cells: a role for blood-borne ligands? (2016) (3)
PRIMARY LIVER CELL CARCINOMA New Insight for a More Correct Approach to its Classification (1987) (3)
Retroviral infection of human neurospheres and use of stem Cell EVs to repair cellular damage (2021) (3)
Role of proteomics in personalized medicine. (2006) (3)
Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription (2022) (3)
Toward detection of toxoplasmosis from urine in mice using hydro-gel nanoparticles concentration and parallel reaction monitoring mass spectrometry. (2018) (3)
Molecular profiling : methods and protocols (2012) (3)
Helicobacter pylori modulated host immunity in gastric cancer patients with S-1 adjuvant chemotherapy. (2022) (3)
Phase I/II trial of autophagy inhibition in combination with neoadjuvant gemcitabine in patients with high-risk pancreatic adenocarcinoma: Safety, clinical response, and correlative studies. (2014) (3)
Importance of disclosure of patent applications (2004) (2)
Radiotherapy alters expression of molecular targets in prostate cancer in a fractionation- and time-dependent manner (2022) (2)
Biology and Biochemistry of Metastatic Cells (1986) (2)
Development of a quantitative PD-L1 assay using laser capture microdissection (LCM)-based reverse phase protein microarray (RPPA) workflow: Implications for precision medicine. (2018) (2)
Multi‐omic molecular profiling guide’s efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial (2021) (2)
Lapatinib and trastuzumab: Molecular effects and efficacy, separately and combined in breast cancer. (2010) (2)
Domains of Laminin and Basement Membrane Collagen which Play a Role in Metastases (1986) (2)
Homologous control of protein signaling networks. (2010) (2)
Use of protein pathway activation mapping of NSCLC to identify distinct molecular subtypes and a prognostic signature for aggressive node-negative tumors. (2010) (2)
Combining the "Sibling Technologies" of Laser Capture Microdissection and Reverse Phase Protein Microarrays. (2019) (2)
Durability of Viral Neutralization in Asymptomatic Coronavirus Disease 2019 for at Least 60 Days (2021) (2)
Next-Generation Techniques for Determination of Protein-Protein Interactions: Beyond the Crystal Structure (2019) (2)
Use of protein pathway mapping of brain metastasis from breast and lung cancer patients to identify new therapeutic targets: A seed/soil study. (2010) (2)
Reverse-phase phosphoproteome analysis (RPMA) of signaling pathways induced by HTLV-1 infection (2011) (2)
Biochemical and Molecular Biology Approaches to Study Cancer Metastases (1986) (2)
Molecular Diagnostics (2003) (2)
Abstract 4787: Novel upfront sample enrichment nanotechnology identifies prostate, breast, colon, ovarian, lung, pancreatic, and melanoma cancer specific biomarker candidates (2012) (2)
Signal transduction pathways in non-small cell lung cancer: Characterization of adenocarcinoma and squamous cell carcinoma histologic subtypes (2004) (2)
Publisher Correction: Antiretroviral Drugs Alter the Content of Extracellular Vesicles from HIV-1-Infected Cells (2018) (2)
The Future of Cancer Diagnostics: Proteomics, Immunoproteomics, and Beyond (2006) (2)
Proteomic profiling identifies prognostic subsets in Rhabdomyosarcoma (RMS) (2005) (2)
Clinical phosphoproteomic profiling for personalized targeted medicine using reverse phase protein microarray (2006) (2)
Alterations of p14 ARF , p53 , and p73 Genes Involved in the E2F-1-mediated Apoptotic Pathways in Non-Small Cell Lung Carcinoma (2001) (2)
Integration of Protein Network Activation Mapping Technology for Personalized Therapy: Implications for Pancreatic Cancer (2014) (1)
Molecular analysis of microdissected tissue: Laser capture microdissection (1999) (1)
Review of AACR meeting: new research approaches in the prevention and cure of prostate cancer, 2-6 December 1998, Indian Wells, CA. (1999) (1)
Chapter 9 – Clinical Proteomics and Molecular Pathology (2009) (1)
Applications of Tissue Microdissection in Molecular Pathology (1998) (1)
Predictive value of topoisomerase 1 by immunohistochemistry (TOP1 IHC) in patients with metastatic breast cancer receiving irinotecan-based therapy. (2016) (1)
Novel Technologies Advance Identification of Metastasis and Invasion-Promoting Genes and Gene Products (2003) (1)
Growth factors and cytokines in tumor invasion and metastasis (1997) (1)
A secretory form of Parkin‐independent mitophagy contributes to the repertoire of extracellular vesicles released into the tumour interstitial fluid in vivo (2022) (1)
Candidate serum biomarkers of doxorubicin-induced cardiotoxicity in pediatric acute lymphoblastic leukemia assessed by nanoparticle-capture mass spectrometry. (2010) (1)
Proteomic and Genomic Profile of High-Risk MDS After Treatment with 5-Azacytidine, (2011) (1)
Immune-modulating Activity of Hydrogel Microparticles Contributes to the Host Defense in a Murine Model of Cutaneous Anthrax (2017) (1)
Abstract P3-04-02: Protein pathway activation mapping of I-SPY 1 biopsy specimens identifies new network focused drug targets for patients with HR+/HER2− tumors (2012) (1)
Chemokine-Releasing Nanoparticles for Manipulation of the Lymph Node Microenvironment. (2015) (1)
Abstract 1889: Can the moonlighting glycolytic enzyme α-enolase be a therapeutic target in pancreatic cancer. (2013) (1)
Nanomedicine--the power of proteins: a conversation with Lance Liotta and Emanual Petricoin. Interview by Barbara J Culliton. (2008) (1)
Protein molecular profiling of archival and frozen fine needle aspirate material in human breast cancer before and after therapy (2005) (1)
Viral Neutralization is Durable in Asymptomatic COVID-19 for at least 60 Days. (2021) (1)
Reverse Phase Protein Arrays: From Technical and Analytical Fundamentals to Applications (2019) (1)
Questions and Answers: OvaCheck TM and NCI/FDA Ovarian Cancer Clinical Trials Using Proteomics Technology (1970) (1)
Analysis of mutational and proteomic heterogeneity of gastric cancer suggests an effective pipeline to monitor post-treatment tumor burden using circulating tumor DNA (2020) (1)
Metastasis and angiogenesis in epithelial ovarian cancer (2003) (1)
Characterization and Validation of Arg286 Residue of IL-1RAcP as a Potential Drug Target for Osteoarthritis (2021) (1)
CHAPTER 11 – HUMAN AMNION AS A NEW QUANTITATIVE MODEL FOR TUMOR INVASION IN VITRO (1985) (1)
Design Principles Underlying Robust Adaptation of Complex Biochemical Networks (2020) (1)
Biological networks with singular Jacobians: their origins and adaptation criteria (2021) (1)
Development and pilot evaluation of a new nanoparticle-capture workflow for doxorubicin-induced toxicity biomarker identification (2015) (1)
Multiple Endocrine Neoplasia Type 1 : Clinical and Genetic Topics Moderator : (2009) (1)
Use of functional protein pathway activation mapping in glioblastoma samples to differentiate long-term from short-term survivors along with pathway-driven molecular subgroups. (2010) (1)
Dual inhibition of DNA double strand break (DSB) repair and PI3K pathway with BEZ235 (BEZ) to sensitize refractory metastatic (met) triple negative breast cancer (TNBC) to nab paclitaxel/cisplatin (pac/cis) in a patient with an exceptional response (ExRx). (2015) (1)
Abstract B49: Alpha-enolase knockdown reprograms metabolism and points out targetable pathways to counteract PDA growth (2015) (1)
Protein pathway analysis in Clinical Proteomics using protein microarrays. (2005) (1)
Retroviral infection of human neurospheres and use of stem Cell EVs to repair cellular damage (2022) (1)
Role of ras Oncogenes in Experimental Models of Metastasis (1986) (1)
Abstract 5575: Mass spectrometry analysis of the posttranslational modifications of alpha-enolase from pancreatic ductal adenocarcinoma cells (2010) (1)
The promise of proteomics. (2003) (1)
Pathologic complete response after preoperative anti-HER2 therapy correlates with alterations in PTEN, FOXO, phosphorylated Stat5, and autophagy protein signaling (2013) (1)
Clinical proteomics and molecular pathology (2020) (1)
Phosphoproteomic profiling of pediatric B-ALL patients with MLL rearrangements (2008) (1)
Discussion of Session (1991) (1)
Frequent post-treatment monitoring of colorectal cancer using individualized ctDNA validated by multi-regional molecular profiling (2020) (1)
Reverse-phase protein microarrays for high-throughput target validation and expression profiling (2003) (1)
Abstract OT3-02-06: Utilizing multiomic advanced diagnostics to identify CDK4/6 inhibitor response predictors and a post-treatment multiomic signature for patients with ER+/HER2- metastatic breast cancer (SIDEOUT-3) (2019) (1)
Multiplex proteomic analysis of cells in fine needle aspiration samples: how soon can we expect to individualize therapy by comparing pre- and posttreatment biopsies? (2014) (1)
Basic techniques for the use of reverse phase protein microarrays for signal pathway profiling (2005) (1)
Tumor invasion and metastasis: getting more basic to come closer to the patient. An interview with Lance A. Liotta. (2004) (1)
Charge Transport Phenomena in Peptide Molecular Junctions (2008) (1)
Development of acquired resistance to lapatinib may sensitise HER2-positive breast cancer cells to apoptosis induction by obatoclax and TRAIL (2018) (1)
Development and Clinical Implementation of Reverse Phase Protein Microarrays for Protein Network Activation Mapping: Personalized Cancer Therapy (2012) (1)
C-109 Nanotechnology: Multifunctional Smart Nanoparticles Measure Previously Invisible Diagnostic Analytes (2014) (1)
A reevaluation of annexin I expression in normal breast and breast carcinoma (2005) (1)
Biomarkers for predicting cancer in women with a suspicious mammogram. (2020) (1)
Abstract 3129: PD-L1 expression differs across cancer metastatic sites from breast tumors (2018) (1)
Phase I/II personalized therapy trial for metastatic colorectal cancer using functional pathway mapping: Stratification to imatinib therapy. (2010) (1)
A response to the two faces of autophagy in DCIS (2011) (0)
Mapping protein signal pathway interaction in sarcoma bone metastasis: linkage between rank, metalloproteinases turnover and growth factor signaling pathways (2013) (0)
Abstract 2912: Protein pathway activation mapping of leukemia-associated JAK1 mutants (2011) (0)
Rapid Detection of Biological and Chemical Threat Agents Using Physical Chemistry, Active Detection, and Computational Analysis (2007) (0)
Proteomic Profiling of Hepatic Metastases: Paving the Way to Individualized Therapy (2011) (0)
Interferon enhancement oftheinvasive capacity ofEwingsarcoma cells invitro (homogeneous interferon/basement (1982) (0)
93: A Panel of Potential Diagnostic Biomarkers for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (2007) (0)
Pre-existence of invasive cells in breast ductal carcinoma in situ. (2010) (0)
MurineI-An0 ChainPolymorphism: Nucleotide Sequences ofThreeAllelic I-AD8 Genes (1982) (0)
Abstract 5180: The neuroreticular axis modulates cell signaling kinases in bone metastasis (2011) (0)
Biochemistry and molecular genetics of cancer metastasis : proceedings of the Symposium on Biochemistry and Molecular Genetics of Cancer Metastasis, Bethesda, Maryland, March 18-20, 1985 (1986) (0)
Clinical applications of anti-invasion and anti-metastastatic agents. (1986) (0)
Abstract 982: Functionally important hotspot interfaces between immune-oncology targets PD-1 and PD-L1 and between Hippo pathway targets YAP2 and tight junction protein ZO-1 are identified using a protein-protein interaction technique optimized with novel dye chemistries (2019) (0)
Erratum: Pilot and feasibility study: Prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways (Breast Cancer Research and Treatment (2012) 132 (487-498) DOI: 10.1007/s10549-011-1609-9) (2012) (0)
Abstract 3312: Protein activation pathway analysis of glioblastoma stem cells reveals potential novel biomarkers (2011) (0)
Clinical proteomics (2007) (0)
DCIS neoadjuvant therapy: Targeting the autophagy pathway in malignant precursor cells. (2010) (0)
2.29 Circulating CLL Cells Expressing Markers of Clinical Aggressiveness Display a Phosphoproteomic Profile Consistent with a Constitutive Receptor Engagement (2011) (0)
8 – Receptor—Ligand Interactions: Role in Cancer Invasion and Metastasis (1991) (0)
Development and Implementation of Array Technologies for Proteomics: Clinical Implications and Applications (2011) (0)
Summary by Moderator (1991) (0)
Vitreous Proteome in Wet Macular Degeneration vs. Non-Neovascular Disease (2008) (0)
Using reverse phase protein microarrays to monitor the state of signal transduction pathways (2003) (0)
Non-enzymatic, serum-free tissue culture of pre-invasive breast lesions for spontaneous generation of mammospheres. (2014) (0)
Microdissecting the molecular stages of cancer progression, invasion and metastasis (1997) (0)
Efficacy of a Novel Inhibitor of Selected Signal Transduction Pathways Including Calcium , Arachidonate , and Inositol Phosphates 1 (2006) (0)
Treatment with TKIs Overcomes Imatinib Resistance through the PLCgamma-1 Signaling Pathway In Imatinib Resistant Human CML Cell Lines (2010) (0)
Clinical Proteomics in Molecular Genetic Pathology 11 (2013) (0)
Ex Vivo Multiplexed Signal Pathway Inhibitor Treatment Reveals Differential Sensitivity of Myeloma and Non-Myeloma Bone Marrow Cell Populations. (2009) (0)
Development and Use of Reversed‐Phase Protein Microarrays for Clinical Applications (2008) (0)
The production and use of human nm23-H2 protein and on the other hand directed antibodies (1990) (0)
Serotonin Dysregulation Correlates with Both Bone and Active Disease In Multiple Myeloma (2010) (0)
Topic 2. Participation of host cells: resistance or collaboration? (2004) (0)
The relationship of tumor vessels, tumor cell clumps and pulmonary metastases. Abstr. (1975) (0)
Erratum to: Pilot and feasibility study: prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways (2012) (0)
Method and device for determining the presence of antigens in biological fluids (1982) (0)
Corrections (2006) (0)
Evaluation of autophagy as a therapeutic target for DCIS. (2012) (0)
Abstract 1080: Nanotechnology-enhanced proteomics analysis of a unique prospective collection of blood samples for the discovery and validation of early detection biomarkers for Non-Small Cell Lung Cancer (NSCLC). (2013) (0)
Nanotechnology Enhanced Immunoassay for Preeclampsia A thesis submitted in partial fulfillment of the requirements for the degree of Masters of Science at George Mason University By (2013) (0)
Personalized therapy for metastatic colorectal cancer: A closer possibility? (2007) (0)
Chapter 34 – Laser Capture Microdissection (2006) (0)
Protein signal pathway mapping: Screening potential drug targets for Multiple Myeloma (2008) (0)
Androgen receptor activation in HER2-negative breast cancer liver metastases. (2016) (0)
Mechanisms of Tumor Invasion and Their Potential Therapeutic Modifications (1985) (0)
Cancer Metastasis and Response to Therapy Correlation of Serum Metalloproteinase Levels with Lung Updated (2006) (0)
Procede de mesure quantitative de collagenase (1991) (0)
Exploring the proteome as a response predictor for rectal cancer undergoing neoadjuvant radiochemotherapy (RCT) (2005) (0)
Toward a systems biology software toolkit (2004) (0)
Abstract 211: Protein painting identifies PD-1: PDL-1 therapeutic targets at protein-protein interfaces (2017) (0)
Abstract B55: Molecular characterization of epithelial and stromal crosstalk associated with TRIM28 expression levels in colorectal cancer (2015) (0)
TB-04PROTEOMICS ANALYSIS OF CEREBROSPINAL FLUID (CSF) FROM CHILDREN WITH CNS TUMOURS IDENTIFY CANDIDATE PROTEINS RELATING TO TUMOUR METASTATIC SPREAD (2016) (0)
Abstract 590: Identification and validation of novel candidate circulating biomarkers in high-grade soft tissue sarcoma (2015) (0)
The revolution in cancer molecular diagnostics. (1996) (0)
Use of Protein Microarrays for Molecular Network Analysis and Signal-Pathway Profiling (2007) (0)
Abstract A65: Effects of alpha-enolase silencing in adenocarcinoma pancreatic cell line. (2012) (0)
LASER CAPTURE MICRODISSECTION: APPLICATIONS IN NEUROPATHOLOGY (1998) (0)
Abstract 3545: New hybrid molecular modalities comprised of DNA-origami and interfering peptides as inhibitors of protein-protein interactions (2022) (0)
Pattern Recognition Algorithms and Disease Biomarkers (2005) (0)
Cancer proteomics in the discovery of new biomarkers for diagnosis and treatment (2008) (0)
Abstract 4575: Covalent incorporation of a new class of dye-based affinity baits in sieving hydrogel nanoparticles overcome roadblocks to cancer biomarker discovery (2010) (0)
Abstract P6-04-01: Protein pathway activation mapping of LCM tumor epithelium from I-SPY 1 TRIAL surgical specimens reveals activation of receptor tyrosine kinase drug target signaling networks in the non-responding patient cohort (2013) (0)
Validation of ATAD2 and cMYC Copy Number and Gene Expression in Breast Brain Metastasis (BBM, n = 42) and Early-Stage Primary Breast Cancer Samples (n = 50). (2014) (0)
312 Protein Pathway Biomarkers Predicting Sustained Virologic Response (SVR) to Pegylated Interferon (PEG-IFN) and Ribavirin (RBV) in Treatment-Naive Genotype 1 Patients With Chronic Hepatitis C (Ch-C) (2010) (0)
Abstract 1874: Investigation of the cerebrospinal fluid proteome from central nervous system pediatric tumors using bait loaded hydrogel nanoparticles and mass spectrometry (2014) (0)
Abstract 3465: Impact of intratumoral protein signaling network activation heterogeneity: Implication for precision medicine (2014) (0)
CHARACTERIZATION OF INTRACELLULAR PROSTATE SPECIFIC ANTIGEN (PSA) IN BENIGN AND MALIGNANT PROSTATIC EPITHELIUM (1999) (0)
Phosphoprotein pathway mapping: AKT/mTOR activation is negatively associated with childhood Rhabdomyosarcoma survival (2006) (0)
Correlation of VEGFR activation within the tumor-associated stroma with an aggressive colon cancer phenotype (2012) (0)
Differential response to growth facl plated on different collagen substra (epidermal growth factor/glucocorticoids/type IV collagen/basement i (2016) (0)
Signaling pathway-based stratification of clear cell renal cell carcinoma. (2012) (0)
Actin Polymerization and Gel Osmotic Swelling in Tumor Cell Pseudopod Formation (1994) (0)
Reevaluation of annexin I expression in benign breast tissue and breast cancer (2006) (0)
Sequence Expressed in Blood Vessels with a Heparin-binding Consensus Identification of a New Immunoglobulin Superfamily Protein Updated (2006) (0)
Abstract 2859: Chloroquine and vitamin D3 modulate proliferation in early stage breast cancer models (2016) (0)
EDITORIALS Stromal Therapy: The Next Step in Ovarian Cancer Treatment (2002) (0)
HER3, PI3K, and JAK2 pathway activation on reverse phase protein microarray (RPMA) in HER2-amplified residual disease (RD) refractory to preoperative chemotherapy plus trastuzumab (H), lapatinib (L), or both (HL). (2015) (0)
Cancer Metastasis: Applications of Proteomics to Metastasis Diagnosis and Individualized Therapy (2011) (0)
Abstract 5377: Profiling of aurora kinase signaling in microdissected gastric cancer samples indicates a significant increase in histone deacetylase 4 (HDAC4). (2013) (0)
Alterations of Cell Signaling Pathways in Pediatric B-ALL Patients. (2006) (0)
Method and apparatus for determining the presence of antigens (1982) (0)
Author response for "Multi‐omic molecular profiling guide’s efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial" (2021) (0)
Methode d'isolement d'analytes provenant d'un echantillon (2006) (0)
Implantation Vessels , and Pulmonary Metastases following Tumor Quantitative Relationships of Intravascular Tumor Cells , Tumor Updated (2006) (0)
Matritzenmetalloproteinasepeptide their effective in diagnosis and therapy (1990) (0)
Abstract 2917: Functional protein pathway activation mapping of the progression of normal skin to squamous cell carcinoma (2011) (0)
730 PROTEOMICS BIOMARKERS PREDICTING HISTOLOGIC NON-ALCOHOLIC STEATOHEAPTITIS AND FIBROSIS (2009) (0)
Association between Helicobacter pylori infection and outcome in advanced gastric cancer patients treated with S-1 adjuvant chemotherapy. (2018) (0)
Noninvasive Biomarkers in Ovarian Cancer (2014) (0)
Abstract 3877: A new frontier for molecular profiling of neoplastic bone tissue (2016) (0)
Abstract P1-07-09: A multi-OMIC analysis to explore the impact of “actionable” genomic alterations on protein pathway activation: Clinical implication for precision medicine in metastatic breast cancer (2017) (0)
Abstract 1353: The clinical utility of ctDNA in colorectal cancer validated by multiregional sequencing and protein analysis (2019) (0)
Use of an ex vivo multiplexed signal pathway inhibitor treatment to reveal sensitivity of myeloma and nonmyeloma bone marrow cell populations. (2010) (0)
Mir-21 Knock Out Creates a Radiosensitive Phenotype and is Therefore a Potential Therapeutic Target (2014) (0)
Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ. (2016) (0)
Apparatus and method for determining the presence of antigenic (1982) (0)
Abstract 3064: MicroRNA-21 enhances the effect of ionizing radiation via alteration of the DNA damage response (2015) (0)
A phosphoproteomic comparison of L858R-mutant with wild-type EGFR signaling in NSCLC cell lines (2007) (0)
Pinpointing a marker protein in papillary bladder carcinomas using SELDI mass spectrometry and microdissection (2004) (0)
Abstract 421: Potential biomarkers for monitoring therapy with Denosumab in patients affected by giant cell tumor of bone (2019) (0)
Editor's page (2005) (0)
PO-485 Low abundance circulating proteins in giant cell tumours of bone (2018) (0)
Abstract 4141: Tumor cell enrichment is critical for assessing cell signaling pathways in glioblastoma multiforme. (2013) (0)
Tumor-Host and Tumor-Stromal Interactions (2003) (0)
Degradation of basement membrane by metastasizing fibrosarcoma cells. Abstr. (1977) (0)
Magnetization of hydrogel particles: a novel urine tuberculosis antigen test (2013) (0)
Identification of serum biomarker candidates for Alzheimer's disease (2009) (0)
Reviewer ' s report Title : Preservation of Biomolecules in Breast Cancer Tissue by a Formalin-Free Histology System Version : 3 Date : 22 August 2007 (0)
Drug Discovery Efforts at George Mason University. (2023) (0)
Abstract 3055: Field cancerization and microbiome in lung cancer (2022) (0)
IABR Conference Room 1004 Title : Biomarkers for Predicting Cancer in Women with Suspicious Mammograms (2021) (0)
Brain microvascular fragility is a major cause of Alzheimer's disease (2009) (0)
LC-MS/MS Validation for Drug of Abuse Testing Utilizing a Split Sample Oral Fluid Collection System. (2020) (0)
Profiling Signal Pathway Activation during Lymphangiogenesis (0)
Comparison of Vitreous Proteome in Cadavaric Subjects and Human Subjects Requiring Vitrectomy (2009) (0)
Abstract 189: Evaluating the influence of Lactobacillus rhamnosus-derived extracellular vesicles on calcium deposition in early breast cancer (2022) (0)
Unconventional Approaches to Direct Detection of Borreliosis and Other Tick Borne Illnesses: A Path Forward (2021) (0)
The topological requirements for robust perfect adaptation in networks of any size (2018) (0)
1081: Signal Pathway Profiles Based on Histologic Grade of Human Prostate Cancer Using Reverse Phase Protein Microarrays (2004) (0)
128 5-Azacytidine induces STAT-5 activation through PLC-y1Tyr783 (2011) (0)
Abstract 1117: Investigating PD-1/PD-L1 checkpoint inhibition as a treatment for platinum-resistant ovarian cancer (2022) (0)
Application of Nanotrap technology for high sensitivity measurement of urinary outer surface protein A carboxyl-terminus domain in early stage Lyme borreliosis (2015) (0)
Phosphoproteomic profiling of pediatric B-ALL identifies in mill patients a new signaling pathway for targeted therapy (2008) (0)
Reviewer ' s report Preservation of Biomolecules in Breast Cancer Tissue by a Formalin-Free Histology System Title : 1 19 April 2007 Version : Date : (0)
Abstract 1067: Somatic genomic mutations, RNA-Seq, and proteomic signal transduction network analysis of tumor and stroma in metastatic triple negative breast cancer (2014) (0)
The role of motility in melanoma metastasis (1994) (0)
Practical Management of Liver Diseases: Novel Technologies in Studying Chronic Liver Disease (2008) (0)
Correction for Students Who Demonstrate Strong Talent and Interest in STEM Are Initially Attracted to STEM through Extracurricular Experiences (2015) (0)
Invasion as a Therapeutic Molecular Target (2003) (0)
Antiretroviral Drugs Alter the Content of Extracellular Vesicles from HIV-1-Infected Cells (2018) (0)
Reverse Phase Protein Microarray Technology (2013) (0)
List of contributors (2020) (0)
Protein network mapping of glucose metabolism in ovarian cancer. (2014) (0)
Extracellular vesicles from HTLV-1 infected cells modulate target cells and viral spread (2021) (0)
Abstract 5413: Multiplexed phosphoprotein cell signaling analysis in multiple myeloma reveals a pro-survival pathway elicited by amino-acid starvation (2017) (0)
Molecular Inhibition of tumor invasion and metastasis. (1982) (0)
Stem Cell Extracellular Vesicles and their Potential to Contribute to the Repair of Damaged CNS Cells (2019) (0)
Application of Proteomic Analysis to Characterize the Molecular Pathways of the Vitreous and Retina in Health and Disease (2006) (0)
Abstract 3516: Reversing extracellular vesicle induced tumor immune suppression at the sentinel lymph node: Role of secretory autophagy and mitophagy (2022) (0)
Abstract P4-10-31: Patterns of protein expression and signaling assessed by reverse phase protein array (RPPA) in estrogen-receptor negative (ER-), HER2-amplified breast cancer (BC) that was primary-refractory to preoperative (preop) HER2-directed therapy (2020) (0)
Proteomic analysis of lymph (Proteomics 2004, vol. 4, issue 3, pp. 753–765) (2004) (0)
Abstract 1994: Impact of laser capture microdissection on cancer signaling proteins and phosphoproteins (2015) (0)
Universal structures for adaptation in biochemical reaction networks (2023) (0)
Publisher Correction: Antiretroviral Drugs Alter the Content of Extracellular Vesicles from HIV-1-Infected Cells (2018) (0)
260 T cell infiltrating repertoire diversity is associated with enhanced survival following neoadjuvant therapy in patients with resectable pancreatic cancer (2020) (0)
Abstract 2925: Protein pathway activation mapping of the NCI60 cell line series: Discovery of lineage-independent protein biomarkers for drug sensitivity/resistance prediction (2011) (0)
A New Structural Model of Apolipoprotein B100 Based on Computational Modeling and Cross Linking (2022) (0)
IL-1 FamilyCytokinesUseDis tinctMolecularMechanisms to Signal through Their SharedCo-receptor Graphical Abstract Highlights (2017) (0)
Antigen-Presenting Signaling Events in the Tumor Ecology Associate with Response to Anti-PD-1 Treatment in Lung Cancer (2019) (0)
Author Correction: Lipoarabinomannan antigenic epitope differences in tuberculosis disease subtypes (2021) (0)
Receptorsystem Foer cellmatris Science anvaendning daerav Foer diagnosticering and treatment of the cancer. (1984) (0)
Protein microarray analysis of aberrant signaling pathways in Acute Myeloid Leukemia to predict the patients responsiveness to PI3K/Akt/mTOR inhibitors (2011) (0)
Profiling of Signal Pathway Activation During In Vitro Lymphangiogenesis (2006) (0)
Proteomic profiling of the epithelial and stromal components of matched normal and colonic carcinomas using protein microarrays (2006) (0)
Abstract 1265: Tissue is alive: Preserving phosphoproteins and tissue morphology in clinical trial samples (2012) (0)
A Novel Urine Method for the Diagnosis of Active Tuberculosis by Immunoassay for the Detection of ESAT-6 Using Hydrogel Nanoparticles in HIV Patients (2021) (0)
plus Ad 2E 1 a ras cHa-but not ras Phenotype : Induction by Transfection with cHa-Secretion of Type IV Collagenolytic Protease and Metastatic (2006) (0)
Advances in Brief Construction of a Representative cDNA Library from Prostatic Intraepithelial Neoplasia (2006) (0)
Advances in Brief Elevated Levels of Mr 92 , 000 Type IV Collagenase in Human Brain Tumors 1 (2006) (0)
Signal-pathway profiling of cells undergoing photodynamic therapy with reverse phase liquid protein arrays. (2004) (0)
over Nonviable Dermal Collagen Produce Collagenolytic Enzymes That Degrade Type I and Type IV Collagen (2010) (0)
Immunoassay using a layered lees antibody conveyor particles to determine the presence of antigen (1987) (0)
Abstract P2-05-21: The AKT-mTOR pathway as a potential organ-specific drug target signature of hepatic metastases from breast cancer (2016) (0)
Phosphoproteomic analysis of metastatic colorectal cancer: A new horizon in targeted therapy development (2006) (0)
Abstract P1-07-05: Triple negative breast cancer metastases: Protein signal transduction networks within the tumor-stromal microenvironment complement genomic analysis and stratify local versus distant metastasis (2015) (0)
Abstract 3290: The Side-Out Foundation Metastatic Breast Cancer Database, an open-access portal for multi-omic molecular data and more (2018) (0)
Comprar Molecular Profiling | Espina, Virginia | 9781603272155 | Springer (2009) (0)
382 PROTEIN PATHWAY BIOMARKER SIGNATURE ASSOCIATED WITH SUPERIMPOSED NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND ADVANCED FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C (2010) (0)
Abstract 4585: Verification of prostate cancer biomarker candidates by nanoparticle-capture MRM (2010) (0)
358 Proteomic pattern analysis serum for early detection of ovarian cancer (2003) (0)
Protein network mapping of platinum-resistant and poor-survival ovarian cancer. (2013) (0)
Functional pathway mapping of human glioblastoma multiforme and brain metastases for patient tailored therapy. (2009) (0)
Cai-resistance proteins coding dna, and their use (1995) (0)
Insulation cellular material under a microscope viewing. (1996) (0)
Peptides de metalloproteinase matricielle: leur role dans le diagnostic et la therapie (1990) (0)
Reverse Phase Protein Microarray Reveals a Correlation Between Akt Activation and Altered Insulin-Like Growth Factor Receptor Expression Following Exposure to Ionizing Radiation (2007) (0)
Isolation d'un materiau sous visualisation microscopique (1996) (0)
Noninvasive Early Biomarkers in Ovarian Cancer (2015) (0)
Laser Capture Microdissection and Microarray Expression Analysis of Lung Adenocarcinoma Reveals Tobacco Smoking-and Prognosis-related Molecular Profiles 1 (2002) (0)
Abstract 2043: Protein pathway activation mapping analysis of metastatic breast cancer reveals potential new targets for personalized therapy. (2013) (0)
Hydrogel particles sequester and preserve low molecular weight, low abundance cancer biomarkers in blood (2008) (0)
Non-invasive monitoring and response prediction for rectal cancer undergoing neoadjuvant radiochemotherapy (RCT) (2005) (0)
Abstract P1-07-23: Pathway activation mapping of metastatic breast cancer identifies potential organ-specific signatures: Implications for patient stratification to targeted treatment (2015) (0)
An Interventional MRI Technique for the Molecular Characterization of Heterogeneous Intra-Prostatic Dynamic Contrast Enhancement (2004) (0)
Importance of disclosure of patent applications. Authors' reply (2004) (0)
Abstract 3476: Chemotherapy modulates proteomic pathways and neuronal metabolites in the brain (2018) (0)
STUDENTJAMA. Molecular technologies for personalized cancer management. (2004) (0)
129 5-Azacytidine activates autophagy independently from disease status and the quality of achieved response (2011) (0)
Protease susceptibilities of HMW, 1 alpha, 2 alpha, but not 3 alpha cartilage collagens are similar to type V collagen. (1982) (0)
Abstract A066: Role of the NRF2 signaling pathway in sustaining chemoresistance in medulloblastoma (2019) (0)
LOW‐MOLECULAR WEIGHT PROTEINS IN NORMAL SUBJECTS AND PATIENTS WIYH INFLAMMATORY LYMPH STASIS: 431 (2004) (0)
New Approach Prevents Invasiveness of Ductal Carcinoma In Situ of the Breast (2012) (0)
Comparison of mRNA and protein expression profiles in the NCI-60 cancer cell panel (2006) (0)
1087 PROTEIN PATHWAY BIOMARKERS PREDICTING SUSTAINED VIROLOGIC RESPONSE (SVR) TO PEGYLATED INTERFERON (PEG-IFN) AND RIBAVIRIN (RBV) IN PATIENTS WITH CHRONIC HEPATITIS C (CH-C) (2010) (0)
Correlation of overexpression of p-EGFR Y1173 with previous irradiation of metastatic triple-negative breast cancer (metTNBC) in African American (AA) women. (2015) (0)
Semi-quantitative protein analysis of HER2 and ER levels in human breast cancer reveals broad expression ranges within HER2+ and ER+ phenotypes. (2009) (0)
Exosomes originating from infection with the cytoplasmic single-stranded RNA virus Rift Valley fever virus (RVFV) protect recipient cells by inducing RIG-I mediated IFN-B response that leads to activation of autophagy (2021) (0)
Technical Advance Sensitive Immunoassay of Tissue Cell Proteins Procured by Laser Capture Microdissection (2000) (0)
Bone metastasis from primary carcinomas and sarcomas: Cell signaling kinase modulation by the neuroreticular axis (2011) (0)
Circulating CLL Cells Expressing CD49d Display a Phospho-Proteomic Profile Consistent with a Constitutive Receptor Engagement by Blood-Borne Ligands (2012) (0)
Role of laminin receptor in tumor metastases. Abstr. (1983) (0)
Method and device for determining the presence of antigens or antibodies (1982) (0)
Methods to Study Ras Oncogene-Mediated Induction of the Metastatic Phenotype (1989) (0)
Abstract 2415: Chloroquine disruption of autophagy: A new treatment for DCIS. (2013) (0)
Therapeutic use of an anti-invasion compound (1990) (0)
Serumproteomic analysis identifiers a Highly sensitive and specific discriminatory pattern in stage I breast cancer (2006) (0)
Abstract 2239: Bone metastasis protein signaling pathway mapping in seven primary tumor types via Reverse Phase Protein Microarray (2010) (0)
Laminin-binding peptide fragments. (1987) (0)
comparative cellular signal patway analysis of metastatic colorectal cancer in human and preclinical animal model (2008) (0)
Functional comparison between genomic subtypes and protein signal transduction networks in metastatic triple-negative breast cancer tumor and stroma to identify actionable therapeutic strategies. (2014) (0)
Multidimensional metamorphosis of biomarker science (2007) (0)
Immunological methods for detecting metastatic-zellaktivitaet (1984) (0)
SIMULTANEOUS APPLICATION OF CHROMOSOMAL MICROARRAY ANAL YSIS AND POLYMERASE CHAIN REACTION GENETIC DISEASE (2014) (0)
Proteomic Analysis of Surrogate Tissues: Mass Spectrometry-Based Profiling of the Circulatory Proteome for Cancer Detection and Stratification (2005) (0)
Levels of parasitemia in infants congenitally infected with T. cruzi . (2014) (0)
Use of a prognostic pathway signature for colorectal cancer comprised of EGFR/COX2 and imatinib drug target activation to predict occult metastasis in M0 CRC. (2009) (0)
Molecular network analysis of signaling pathways in metastatic breast cancer in patients treated with erlotinib. (2006) (0)
Abstract P3-04-01: Protein pathway activation mapping of the I-SPY 1 biopsy specimens identifies new network focused drug targets for patients with triple negative tumors: (2012) (0)
ISN Forefronts in Nephrology Symposium on Cell and Molecular Biology of Basement Membranes in Health and Disease: Introduction (1993) (0)
3 Overview of proteomics with emphasis on diagnosis and monitoring (2004) (0)
Alterations in molecular networks of metastatic colorectal carcinoma reveal organ-specific signatures: Implications for targeted therapy of metastatic disease. (2006) (0)
Alleile Deletion Analysis of the FHIT Gene Predicts Poor Survival in Non-Small Cell Lung Cancer (2006) (0)
Signaling pathway-based stratification of clear cell renal cell carcinoma. (2012) (0)
Sparse Dynamical Network Reconstruction: the EGFR network case (2007) (0)
A study of the genetic progression of human cutaneous malignant melanoma by comparative genomic hybridization (1997) (0)
Protein signal pathway mapping of human breast cancer from I-SPY: Correlations with response and genomic subtyping. (2010) (0)
Immunoassay in layers to determine the presence of an antigen using antibodies which are bound to transport particulate (1987) (0)
Inflammatory Mediators as Therapeutic Targets for Inflammatory Breast Cancer (2012) (0)
Abstract 4911: Systems level network analysis of NCI60 cell lines by alignment of protein pathway activation modules with multiple -omic data fields and therapeutic response signatures (2012) (0)
Improved survival by Helicobacter pylori-modulated immunity in gastric cancer patients with S-1 adjuvant chemotherapy (2021) (0)
Abstract 2229: Molecular profile of histological and mutational heterogeneity of adenocarcinoma of the stomach in tumor burden monitoring using circulating tumor DNA (2019) (0)
Molecular basis of cancer invasion (1994) (0)

This paper list is powered by the following services:

Other Resources About Lance Liotta

en.wikipedia.org

What Schools Are Affiliated With Lance Liotta?

Lance Liotta is affiliated with the following schools:

Lance Liotta's Academic­Influence.com Rankings

Why Is Lance Liotta Influential?

Lance Liotta's Published Works

Published Papers

Other Resources About Lance Liotta

What Schools Are Affiliated With Lance Liotta?

Lance Liotta's AcademicInfluence.com Rankings